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 Anorexia nervosa is the third most common illness among adolescent females.  
Approximately one half the cases of anorexia nervosa have been suggested to be activity-
induced.  Various animal studies have been used to study human anorexia, particularly 
the activity-based anorexia model (ABA).  The ABA paradigm consists of diet restriction 
and liberal access to activity, which ultimately results in a rapid decrease in both body 
weight and food intake paradoxical to the significant increase in activity.  Because 
resistant starch (RS) has been shown to initiate a lower rise and a steady level of post-
prandial blood glucose, it was hypothesized that a diet containing RS would reduce the 
severity of the anorexia associated with the ABA model.  In this study, 56 five-wk old 
male Sprague-Dawley rats were assigned to 8 groups.  Animals were fed a control diet 
(C-diet) or a RS-diet, on an ad libitum or a restricted-feeding (one 90min meal per day) 
schedule, and allowed 22-hr of access or no access to activity wheels.  The study ended 
when a majority of the ABA rats reached <75% of their pre-experimental body weights.  
Within 4 days of the experiment, ABA rats on the RS-diet lost an average 66g of body 
weight compared to an average loss of 31g in the C-diet (p<0.01).  ABA rats on the RS-
diet ran 31% more (NS), despite consuming 30% fewer calories per kg body weight, than 
those on the C-diet (p<0.01).  ABA rats fed the RS-diet had 3.97 times higher levels of 
plasma norepinephrine (NE) compared to their associated controls (p<0.0001); ABA rats 
fed the C-diet had only 1.4 times the NE level of their corresponding controls (NS).  All 
RS-fed rats had an average of 17-50% less fat pad (brown, perirenal, epididymal, & 
retroperitoneal) weights compared to C-fed rats (p<0.02).  Resistant starch exacerbates 




In the U.S., the high availability of various foods, the sedentary lifestyles, and 
society’s standards for the ideal image in men (Leit, Gray, & Pope, 2002) and women 
(Groesz, Levine, & Murnen, 2002) have lead to a wide range of nutritional 
complications.  For example, the public encountered and continues to struggle with the 
problem of obesity.  More than sixty percent of the U.S. population is either overweight 
or obese (Must et al., 1999), and the prevalence of children with obesity is increasing 
(Birch & Fisher, 1998).  Overweight is defined as being 10-20% above the ideal body 
weight (IBW) (Forsythe, 1998) or a body mass index (BMI) of 25-29 (Laquatra, 2000).  
Obesity is defined as being 20% above the IBW (Forsythe, 1998) or a BMI of >30 
(Laquatra, 2000).  The medical consequences of obesity include, but are not limited to, 
increased risks of cardiovascular diseases, joint diseases, gall bladder diseases, cancer, 
diabetes, hypertension, lipid disorders, and gout (Forsythe, 1998; Laquatra, 2000; Must et 
al., 1999). 
On the other hand, there are people who are struggling with severe underweight 
and eating disorders, both of which can eventually lead to a complex state of malnutrition 
or death if left untreated.  Eating disorders are considered a physiological or a 
psychological problem, depending on the disorder.  One of the most common types of 
eating disorders is anorexia nervosa.  Anorexia nervosa (AN) is an eating disorder 
characterized by the failure to maintain a body weight within 15% of one’s IBW, 
distorted food beliefs or food aversions, intense fear and refusal of gaining weight, 
excessive weight loss, amenorrhea in females, and sometimes obsessive activity.  
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Individuals with AN have a distorted body image, that is, they perceive themselves as 
being overweight despite their emaciated status, and they are often in denial of their 
condition (Forsythe, 1998; Schebendach & Reichert-Anderson, 2000).  However, it is 
well worth stating that the literal meaning of anorexia is the loss of appetite, especially 
when prolonged. 
Anorexia nervosa can lead to many medical outcomes that include a weakened 
immune system, anemia, delayed gastric emptying, organ damages, irregular heartbeats, 
changes in the central nervous system, low body temperatures, low blood pressures, 
pubertal delay in children, and the disruption of menstrual cycles in females 
(Schebendach & Reichert-Anderson, 2000).  It has been estimated that approximately 6% 
of anorexics die from anorexia nervosa (Forsythe, 1998).  If AN is detected and treated 
early in the disorder, there can be a decline in the mortality rate by 10%, and up to 80% 
of the involved individuals may either fully or partially recover (Becker, Grinspoon, 
Klibanski, & Herzog, 1999). 
Past research suggested that one in every 800-1000 females are associated with 
anorexia nervosa, but it is now estimated that one out of every hundred young females 
have the disorder (Forsythe, 1992).  The most common period of onset seems to be 
during adolescence (Schebendach & Reichert-Anderson, 2000).  Girls between the ages 
of 9-14 have reported a desire to be thinner and have attempted dieting (Halvarsson, 
Lunner, Westerberg, Anteson, & Sjoden, 2002).  More attention is given to females 
because the majority of the reported cases are primarily females; however, the rate of 
incidence in males is increasing (Forsythe, 1998).  Males account for approximately 5-
10% of all eating disorders (Carlat, Camargo, & Herzog, 1997), and it is suggested that 
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incidences for males are lower than that for females because males tend to be less 
dissatisfied about their weight (Sisson, Franco, Carlin, & Mitchell, 1997).  Other 
researchers, however, have reported findings that males were more disturbed about their 
weight than females (Sorbara & Geliebter, 2002).  Nevertheless, whether males or 
females are more displeased about their weights, it has been strongly indicated that the 
media plays a large role in rendering the negative perception about body size, shape and 
weight (Groesz et al., 2002; Leit et al., 2002). 
A common characteristic of individuals with anorexia nervosa is increased 
physical activity.  Furthermore, it has been suggested that this increase in activity is one 
of the first signs to appear abnormal and one of the last few to normalize (Kron, Katz, 
Gorzynski, & Weiner, 1978).  Therefore, the proposed study is designed to model the 
anorexia found in highly active individuals.  Because the weight loss of anorexia can be 
attributed in part to the combination of low energy intakes and high-energy expenditures, 
there must be a way to ameliorate the weight loss effect—if not entirely preventing it 
from occurring.  The best probable alternative may be to prolong the progression to 
anorexia, rather than solely attempting to reverse it.   
In the proposed study, young male rats are subjected to the standard activity-
based anorexia (ABA) model that consisted of a simultaneous exposure to restricted 
feeding schedules and liberal access to running wheels.  Activity-based anorexia (ABA) 
can be defined as the reduction of food intake and a progressive loss of body weight that 
is paradoxical to an increase in wheel running.  In the intended study, it was predicted 
that the rats would continue to run while their food intake is decreased.  Because there is 
no compensation for the energy expended on the running wheels, the rats will continue to 
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lose weight.  The result of this procedure, if allowed to continue for several days, can 
lead to severe loss of body weight and eventual death if the rats are not removed from the 
experiment.  ABA has clinical significance because some patients with anorexia nervosa 
often use intense exercising and diet restriction as a means of losing weight and 
maintaining the weight loss (C. Davis, Kennedy, Ravelski, & Dionne, 1994; Kron et al., 
1978). 
Objective and Hypothesis 
 The objective of this study is to determine whether the outcomes of the activity-
based anorexia (ABA) paradigm can be attenuated if the diet contained resistant starch.  
It is hypothesized that if the animals are fed a diet containing resistant starch while 
exposed to the standard ABA procedure, the effects of the ABA model will be 
ameliorated. 
Rationale and Justification 
 A high glycemic diet produces transient post-prandial hyper- and hypo-glycemia. 
Conversely, because animals fed a resistant starch, which has a low glycemic index, 
slowly digest and absorb glucose, they are able to maintain euglycemia for a longer 
period of time when compared to those fed a high glycemic index diet (Raben, Kiens, & 
Richter, 1994).  Because euglycemia is sustained over a longer time frame, there should 
be less, if any, stimulation of catabolic hormone release, and thus, energy stores will not 
be catabolized.  Higher body stores of energy (e.g., fat, protein, glycogen) are suggested 
to attenuate wheel running associated with ABA (Fish & Lewis, 1996); therefore, it is 
possible that a resistant starch diet may attenuate the outcomes of ABA. 
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Assumptions  
1. The activity-based anorexia paradigm is an acceptable model of human anorexia. 
2. The blood and tissue collections from the animals are representative of humans.  
3. The animals are free from any diseases or disorders that may affect the results. 
4. The design of the run-test(s) will allow appropriate determination for the 
assignment of animals to specified groups. 
Limitations  
1. Psychological issues, which are evident in human anorexia nervosa, cannot be 
evaluated in rats, thus the model lacks psychological representation of this 
disorder. 
2. Possible gender differences were not identified because experiment(s) did not 
simultaneously consist of both male and female rats due to limited laboratory 
space and equipment. 
3. The number of animals used may not be sufficient to generate a reliable 
conclusion. 
4. The intensity, frequency, and duration were not measured due to lack of 
equipment and programs. 
 6
CHAPTER 2 
REVIEW OF LITERATURE 
Societal influences have put a great deal of pressure on its people.  Overemphasis 
on health, fitness, beauty, and achievements has caused many to be at harm.  For 
example, males and females struggle to be thin and fit in order to adhere to the standard 
of the ideal man or woman (Silverstein & Perdup, 1998).  Athletes in competitive sports 
strive to be at certain body weights in order to compete at their maximum potential 
(Stoutjesdyk & Jevne, 1993).  Military soldiers are expected to put great effort in 
reaching or maintaining body weight within strict standards.  A report by McNulty (1996) 
indicated that many people in the U.S. Army, Navy, Marines, and Air Force were 
discharged or failed to get a promotion because they were overweight (McNulty, 2001).  
In a study by Rose et al. (1993), Army soldiers indicated that appearance, health 
concerns, and upcoming weigh-ins were the primary reasons for attempting weight loss 
(McNulty, 2001).  However, there is danger when dieting individuals develop eating 
disorders.  They may become emotionally obsessive about their appearance, which may 
result in abnormal eating patterns (i.e., binging, purging, starving) or abnormal exercising 
routines to a point of severe malnourishment and physiological and psychological 
complications (Becker et al., 1999; Rock, 1999).   
Eating disorders affect people of all ages, especially adolescent females, for 
whom it is the third most common chronic illness (Kreipe & Birndorf, 2000).  Over five 
million Americans suffer from some form of eating disorder (Adolescent Medicine 
Committee & Canadian Paediatric Society, 1998).  Research shows that more females are 
reported to have eating disorders than are males, who make up only 5-10% of the 
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population with eating disorders (Carlat et al., 1997).  In addition, there is a higher 
prevalence among explicit groups in which diet restriction and regulation of body weight 
is of great importance (e.g., ballerinas, dancers, marathon runners, or models) (Carlat et 
al., 1997; Engstrom et al., 1999).  Because eating disorders are more than merely medical 
complications, they are usually treated with the help of an interdisciplinary team (e.g., 
medical professionals, nurses, dietitians, and psychiatrists), family, relatives, and close 
friends (Adolescent Medicine Committee & Canadian Paediatric Society, 1998). 
 Examples of eating disorders include, but are not exclusive to, anorexia nervosa 
(AN), bulimia nervosa (BN), and eating disorders not otherwise specified (EDNOS).  
EDNOS is a less severe form of AN and BN that is estimated to occur in approximately 
1-2% of the population and makes up 50% of all eating disorders.  An individual with an 
eating disorder is classified as having EDNOS if he or she has not met all the criteria of 
any specific eating disorder.  For example, in the fourth edition of Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV-TR), a female is diagnosed with having 
EDNOS if she has met all criteria for AN but continues to have regular menses.  EDNOS, 
however, can develop into AN or BN if left undiagnosed and untreated (Spear & 
Stellefson, 2001).    
Bulimia nervosa is an eating disorder characterized by repeated episodes of 
binging with subsequent purging and feelings of guilt.  Unlike anorexia nervosa, 
individuals with BN are usually at normal or above normal weights.  According to the 
DSM-IV-TR, in order to be diagnosed with BN, an individual  (1) must have “recurrent 
episodes of binge eating” and a “recurrent inappropriate compensatory behavior,” in an 
attempt to prevent weight gain, for at least twice a week for a period of three months; (2) 
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must evaluate his or her self by means of body shape and weight; and (3) must not be 
diagnosed with anorexia nervosa.  BN occurs in 2-5% of the population (Spear & 
Stellefson, 2001). 
Anorexia nervosa is a psychiatric disorder in which individuals have distorted 
body images, even if underweight, and have distorted food beliefs.  The individuals are 
usually <85% of their ideal body weight (IBW) or have a body-mass index (BMI) of 
<17.5 (Becker et al., 1999).  The DSM-IV-TR states that to be diagnosed as having AN, 
one must (1) refuse to maintain body weight at or above standard weight for one’s age 
and height; (2) have an intense worry of weight gain or fat gain even if one is under 
weight; (3) have a distorted body image; and (4) have amenorrhea if she is post-
menarcheal (Spear & Stellefson, 2001).  AN is the only psychiatric disorder that requires 
a biological abnormality (i.e., amenorrhea) for diagnosis in females (C. Davis, 1997).  
Death from AN is usually due to starvation, suicide, or electrolyte imbalance (McNulty, 
2001). 
 Many health complications result from eating disorders.  For example, in AN, 
symptoms can range from brittle hair and nails, dry skin, severe constipation, 
hypoglycemia, and hypotension to bradycardia, delayed gastric emptying, osteoporosis, 
and other cardiovascular complications (e.g., reduced heart mass) (Bachrach, Guido, 
Katzman, Litt, & Marcus, 1990; Becker et al., 1999; Cooke & Chambers, 1995; Fisher et 
al., 1995; Kreipe & Birndorf, 2000; Rock, 1999; Swenne, 2000; Webb, Kiess, & Chan-
Yan, 1986).  In addition, BN symptoms include gastrointestinal problems, esophageal 
reflux disease, muscle weakness, fatigue, cardiac arrhythmias, dehydration, electrolyte 
imbalances, and dental erosion (Mitchell, Hatsukami, Eckert, & Pyle, 1985; Rock, 1999).  
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Furthermore, in any of the eating disorders the medical complications may be deemed 
irreversible (i.e., retarded growth or hindered puberty) if the individual is not diagnosed 
and treated (Abrams et al., 1993; Fisher et al., 1995).    
Human Studies 
In 1997, 1.1% of the active duty U.S. female Navy nurses who participated in a 
study were diagnosed with anorexia nervosa, which was comparable to the incidence of 
AN in the U.S. national population (McNulty, 1997a).  However, researchers found that 
the incidence of BN was six times greater for the Navy nurses than that of the U.S. 
population.  Another study in 1997 showed that there was a 2.5% and 6.8% incidence of 
AN and BN, respectively, in a study of 4,800 Navy men (McNulty, 1997b). 
Edholm and associates reported that cadets ingest less food on days of military 
drilling than they do on days of lower activity (Edholm, Fletcher, Widdowson, & 
McCance, 1955).  In a correlational study of 1,278 anonymous females in the armed 
services (U.S. Army, Navy, Air Force, and Marines in Okinawa, Japan), surveys showed 
that body fat averaged 19.5% for the total sample and amenorrhea was significantly 
higher among members of the Marines—this was found to reflect the youngest 
population.  The Marines also reported the highest use of diet pills and laxatives and the 
highest rate of vomiting.  Participants indicated increased episodes of binging or purging 
during the biannual Physical Readiness Test (PRT).  The surveys showed that the most 
frequently used method for attaining one’s appropriate weight was fasting, followed by 
binging and the use of diet pills (McNulty, 2001). 
Reports suggest that much of human anorexia may be activity-induced (Crisp, 
Hsu, Harding, & Hartshorn, 1980; C. Davis et al., 1994; King, Burley, & Blundell, 1994).  
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Exercise has been known to reduce weight in some individuals and possibly the amount 
of food consumption per day if all other factors (e.g., age, sex, diet, duration and intensity 
of exercise) are taken into account (Durrant, Royston, & Wloch, 1982; Pi-Sunyer & Woo, 
1985; Thompson, Wolfe, & Eikelboom, 1988).  Nonetheless, the connection between 
activity and food consumption primarily contributes to the balance of energy (King et al., 
1994).  The effects of exercise on energy intake in normal-weight young people (10 men 
and 10 women) were examined.  Participants were given a diet individualized to their 
needs and were randomly assigned to either an exercising group (1 hour/day of treadmill 
at ~68% of VO2max for five days) or to a sedentary group (no treadmill exercise).  
Although there was a significant increase in caloric intake by exercising men and no 
significant increase for exercising women, all the active participants were in negative 
energy balance during the exercise period (Staten, 1991). 
In another study, the effect of intensity and duration of exercise on energy 
consumption was studied in twenty-three healthy male participants.  In part one of the 
study, the participants were assigned to a control group, a low-intensity exercising group, 
or a high-intensity exercising group.  In part two of the study, participants were assigned 
to a short-duration exercising group, a high-duration exercising group, or a control group.  
In part one, there was no reduction of hunger in those in the low-intensity group at any 
time.  Conversely, there was a short-lived suppression of hunger during exercise and 15 
minutes immediately following exercise for those in the high-intensity group.  There was 
no effect on total caloric consumption among any groups.  In part two, there was a 
significant decrease in hunger during both the short- and long-duration exercise periods.  
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In addition, hunger suppression continued after exercising with the greatest suppression 
for those in the long-duration exercise treatment (King et al., 1994). 
Animal Models 
Animal models of anorexia have been used for nearly 50 years (J. F. Hall & 
Hanford, 1954).  Many animal studies used rats as a model for human anorexia, but the 
animal paradigm has also been performed with mice (Epling, Pierce, & Stefan, 1983), 
hamsters, gerbils, and guinea pigs (Vincent & Pare, 1976).  It was Epling and co-authors 
who coined the term “activity-based anorexia” and proposed a link between anorexia in 
animals to anorexia nervosa in humans (Epling et al., 1983).  However, activity-based 
anorexia may also be referred to as “self-starvation” (Routtenberg & Kuznesof, 1967; 
Spatz & Jones, 1971) or “activity-stress” procedures (Pare & Houser, 1973).  The former 
was the original name given to this paradoxical effect and the latter is usually used in the 
context of studies focusing on stomach ulcerations.  Therefore, because activity-based 
anorexia is a term widely used, it will be used throughout the present literature review to 
refer to the negative effects that result from severe food restriction and excessive activity. 
Activity-based anorexia (ABA) has been typically characterized by a reduction in 
food intake and body weight paradoxically accompanied by a progressive increased 
activity level (Dwyer & Boakes, 1997).  A standard activity-based anorexia (ABA) 
animal model includes simultaneous introduction of diet restriction (one meal for 60-90 
minutes per day) and access to running wheels (21-22.5 hours of access per day) to the 
animals in the experimental condition.  For example, in a study that restricted the 
mealtime to 60 minutes per day and allowed access to running wheels for the remainder 
of the day, the animals continued to increase their activity, reduce their food intake, and 
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lose weight on succeeding days.  Over a short period, the animals died because the 
amount of calories consumed failed to compensate for the energy expended from the 
running (J. F. Hall & Hanford, 1954; Routtenberg & Kuznesof, 1967).  A typical rat 
would display an initial gradual rise in activity levels and then show a dramatic increase 
if the experiment was allowed to continue.  Moreover, as activity levels increased (i.e., 
more than 5,000 revolutions per day), the rats’ food intake and body weight declined 
considerably (Beneke, Schulte, & vander Tuig, 1995; Epling & Pierce, 1984).   
In a study by Tokuyama and lab, rats showed an initial transient reduction in food 
intake and a rapid increase in running for the first 5-10 days, followed by an increase in 
food consumption that surpassed the amount consumed by the controls (Tokuyama, 
Saito, & Okuda, 1982).  Studies have shown that experimental rats can run more than 1 
km per day (Boakes, 1997) and eat less than 1 gram per day (Routtenberg & Kuznesof, 
1967).  Thus, as Epling and co-authors state:  “animal research on self-starvation suggests 
that the combined effects of these variables are multiplicative rather than additive (p. 41)” 
(Epling et al., 1983).  Much research has been performed in an attempt to determine the 
reason behind this phenomenon.  Some researchers suggest that the animals drastically 
increase their running in order to raise their body temperatures, because animals that fail 
to adapt to the restricted feeding schedules were found to have low body temperatures 
(Lambert, 1993).  Nevertheless, there are many controversial issues such as whether or 
not the introduction of both stress factors (i.e., novelty to wheels and deprivation of food) 
must be presented simultaneously (Ness, Marshall, & Aravich, 1995), whether females or 
males are more vulnerable to this procedure (Boakes & Dwyer, 1997; Doerries, Stanley, 
& Aravich, 1991), or whether decreased food intake causes increased running or vice 
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versa (Boakes & Dwyer, 1997; Epling & Pierce, 1988; Lett, Grant, Smith, & Koh, 2001).  
Because the majority of the experiments prevented running during the feeding period, the 
effects of ABA cannot be attributed to the competition between food and activity. 
Routtenberg and Kuznesof defined anorexia in the rat as the consumption of less 
than 1 gram of food (Routtenberg & Kuznesof, 1967).  However, because the older 
definition was too rigorous, animals are now classified as being “anorexic” if their body 
weight has declined to 70% of their initial body weight, which is the weight loss criterion 
used more in the context of activity-stress ulcers (Doerries et al., 1991; Epling & Pierce, 
1984).  Animals are considered to have reached the “removal” or “starvation” criterion if 
they have reached 75% of their pre-experimental body weight on two consecutive days 
(Beneke et al., 1995; Boakes, Mills, & Single, 1999).  Animals are said to have met the 
“recovery” or “survival” criterion when their weight on day 4 is at or above the weight on 
day 1 in any consecutive 4-day period (Beneke et al., 1995; Epling & Pierce, 1984). 
 Pre-existing characteristics such as pre-experimental body weight, age, and 
gender seem to play a role in achieving the ABA results.  Boakes and Dwyer found that 
male rats with low initial body weights (180g on average) lost weight faster than those 
with higher initial body weights (205 on average) although all rats were at the same age 
(Boakes & Dwyer, 1997).  Routtenberg and Kuznesof indicated that rats weighing 
approximately 270g at the start of an experiment are highly vulnerable to the ABA effect 
(Routtenberg & Kuznesof, 1967).  Rieg and associates suggested that an animal with an 
initial body weight of more than 350g is less likely to reach a 25% weight loss (Rieg, 
Maestrello, & Aravich, 1994).  Woods and Routtenberg found that age was a very 
important factor in the vulnerability of male rats to ABA.  They discovered that younger 
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male rats (less than 10 weeks old) lost weight faster than did the older rats (over 10 
weeks old).  Because the growth rate is quicker for males and especially rapid over the 
first 70 days of a rat’s life, maturation is a confounding variable that should be considered 
(Woods & Routtenberg, 1971).   
Some studies have evaluated gender as another variable in ABA experiments; the 
results, however, are lacking consistency.  A study by Boakes and co-workers included 
two female groups and one male group in an attempt to match age, weight, and gender 
factors.  One female group (FY; 52 days old; 160g) was age-matched to the male group 
(MY; 52 days old; 230g).  A second female group (FO; 136 days old; 237g) was weight-
matched (mean value of ~230-237g) to the MY group.  Results of the study demonstrated 
that both age and gender, rather than weight, are strong factors in the standard ABA 
procedure; however, age seems to be a more critical aspect in this study.  The FY and 
MY groups reached the “removal” criteria in an average of 7.0 and 7.4 days, respectively.  
However, it took the FO group an average of 10.83 days to reach the removal criteria 
(Boakes et al., 1999).  These findings are consistent with another lab that found that 
female rats are more vulnerable to the effects of diet restriction and excessive activity 
than are male rats (Pare, Vincent, Isom, & Reeves, 1978).   
In a different study, researchers attempted to match the weights and age for both 
male and female rats.  In contrast to the findings above, these researchers found that 
females ran and ate more than the males, and the male rats lost weight faster than the 
female rats, even though the male rats weighed a mean value of 10g more than the female 
rats weighed (Doerries et al., 1991).  Consistent with this study in some aspects, an even 
earlier study evaluated the effects of running and food restriction on male and female 
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rats.  They found no differences in food consumption and weight changes between 
sedentary males and sedentary females.  However, they did find that active female rats 
recovered from the reduced food intake faster than did the active males.  Even though, 
the exercising females ran consistently more (a plateau on day 10 of 11,000 revolutions 
per day) than did the exercising males (a plateau on day 10 of 4,000 revolutions per day) 
throughout the 50-day experiment (Tokuyama et al., 1982). 
Roy and Wade found that estrogen is an activity-promoting hormone in both male 
and female rats.  Their finding supported the argument that females acquire some 
characteristics that promote higher activity than do males (E. J. Roy & Wade, 1975).  In 
another study that attempted to determine whether activity levels and survival rates were 
affected by rats (males and females) subjected to gonadectomization and introduced to 
the activity-stress (AS) paradigm, researchers found that the castrated animals showed a 
reduction in activity but there were no sex differences in activity levels.  They also found 
that the males survived longer than the females (6.0-6.3 versus 4.1-4.3 days), and the 
castrated rats died earlier than the sham-operated rats.  Because the animals in the study 
were castrated and matched according to age, sex, and weight, it was proposed that when 
these three factors are controlled, the difference in vulnerability between males and 
females is diminished (Lambert & Kinsley, 1993). 
Activity-based Anorexia (ABA) Variations 
 Prior exposure to deprivation stress or novelty stress has been found to affect the 
results of the activity-based anorexia paradigm.   However, questions remain as to which 
determinant, for example, variations in activity patterns, meal frequencies, or housing 
conditions, play a more critical role.  Routtenberg isolated the variables relating to ABA 
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in an attempt to further study the paradoxical effect of the ABA paradigm.  He defined 
“deprivation stress” as the stress resulting from the introduction of food restriction and 
“novelty stress” as the stress related to exposure to a new environment (running wheels).  
It was concluded that deprivation stress was essential for the “starvation” effect and 
novelty stress only reinforced these effects (Routtenberg, 1968).   
Kanarek and Collier proposed that the introduction of activity might interact with 
a satiety mechanism that causes the termination of eating and that the initiation of ABA is 
caused by a failure to adapt to a restricted feeding schedule (Kanarek & Collier, 1979).  
Since then, much research has been done to pre-expose and adapt the laboratory animals 
to one of the two stress factors before administering the second stress factor.  In one 
study, researchers have found that pre-exposure to wheel running increases the rate at 
which weight loss occurs when a diet restriction is later imposed (Boakes & Dwyer, 
1997).  In a different study, running alone dramatically reduced body weight to the extent 
that the experiment was terminated before food restriction was introduced (Verna Rose 
Burden, 1992).   
Unlike pre-adaptation to running, researchers tested the effects of pre-adaptation 
to the restricted feeding schedule and determined the minimum feeding period required 
for severe weight loss and ulcer development.  The rats were divided into twelve 
treatment groups.  Six groups were pre-adapted to either a 1-hour or a 2-hour feeding 
schedule and the other six groups remained on ad libitum feeding.  All animals were 
further divided into groups receiving 9, 18, or 24 days of acclimation to the feeding 
schedules.  When access to running wheels was introduced, the pre-adapted animals 
remained on the same feeding schedules while the freely fed animals received the same 
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restriction as those of the pre-adapted group.  Results showed that with exposure to the 
wheels, pre-adapted rats ate more than the freely fed rats.  In addition, the animals 
allowed the longest acclimation period ate and weighed more than those allowed shorter 
acclimation periods.  The non-adapted animals had a larger decline in body weight when 
allowed access to running wheels (Pare, Vincent, & Natelson, 1985).   
Consistent with these findings other researchers also found that pre-adapted rats 
lost less weight and ate more than the non-adapted rat, which led to the conclusion that 
prior adaptation to the feeding schedule can reduce the severity of ABA outcomes (V. R. 
Burden, White, Dean, & Martin, 1993; Dwyer & Boakes, 1997).  Contrastingly, Lett and 
co-workers found that pre-adaptation to diet restriction did not eliminate ABA in rats.  
The experimental animals that were adapted to the feeding schedule still ate less, weighed 
less, and ran more than those of the control group (Lett et al., 2001).  Nevertheless, 
researchers concluded that if the paradigm was not as stringent as the typical ABA 
procedure (i.e., feeding period of up to 2.5 hours during adaptation period and allowing 
only 2 hours of wheel access prior to feeding rather than 90 min meal period and 22.5 hr 
of access to wheel-running), rats who are pre-adapted to the restricted feeding schedule 
show faster recovery than those who are non-adapted (Boakes & Dwyer, 1997). 
 The duration of the meal period also appears to take part in attaining anorexia.  
For example, experimental rats were fed for 30, 45, or 60 minutes per day and were 
restricted from activity one hour before feeding time.  The control rats were restricted on 
the same feeding schedule as described earlier but did not have access to activity wheels.  
The results showed that all the animals in the experimental groups “starved” (starvation 
criterion was defined as easing less than 1 gram during the feeding period) except for one 
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rat from the 60-minute group, and all the animals in the 30-minute control groups 
“starved” compared to one animal in the 60-minute control group (Routtenberg & 
Kuznesof, 1967).  Comparably, researchers found that ABA was more likely to be found 
when the rats were fed 60 minutes per day rather than 120 minutes per day, and it was 
more likely to occur when the rats were given a single feeding rather than multiple 
feedings (Kanarek & Collier, 1979; Pare et al., 1985).  For example, when there was a 
variation in the frequency of the meals throughout the day, i.e., four 15-min, two 30-min 
and one 60-min meal, animals fed the one 60-min meal demonstrated anorexia 
characteristics as opposed to those fed four 15-min meals.  It was suggested that ABA 
resulted from the failure to overcome satiety signals rather than solely from an activity-
induced food intake suppression (Kanarek & Collier, 1983). 
It has long been determined that rats are nocturnal eaters and there are two peak 
eating periods—one at the onset of the dark cycle and the other at the end of the dark 
cycle (Dwyer & Boakes, 1997; Kersten, Strubbe, & Spiteri, 1980).  Thus, to raise the 
intricacy of adapting to the restricted feeding schedule, most experiments schedule the 
feeding times during the light cycle.  In an attempt to further study this phenomenon, 
researchers tested whether the time of day of feeding has an effect on adaptation to a 
restricted feeding schedule.  The results showed that animals adapted to the feeding 
schedule faster when fed during the dark cycle than when fed during the light cycle 
(Dwyer & Boakes, 1997).  Furthermore, Burden and lab, which wanted to control for 
circadian rhythms in order to measure metabolites in the hypothalamic-pituitary-adrenal 
axis, demonstrated that animals fed during the dark cycle could still reach the state of 
activity-based anorexia (Verna Rose Burden, 1992). 
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It is suggested that variable access to running wheels may have an effect on the 
typical ABA outcome.  For example, Epling and Pierce allowed varying amounts of time 
of wheel access (2, 6, 12, 18, or 22 hours per day) for the experimental rats that were 
restricted to a daily 90-minute feeding schedule.  They found that rats that had more than 
12 hours of access to running wheels indicated evidence of severe ABA (Epling & 
Pierce, 1984).  In another example, rats were allowed 30 minutes of feeding time per day 
and restricted from activity for either up to 2 hours before or up to 2 hours after feeding 
period.  All of the experimental animals died within a mean number of 13.5 days.  In a 
further experiment, these researchers allowed the rats a 60-minute feeding period in 
which wheel running was restricted for up to 3 hours before the meal.  The results 
showed that three out of five rats starved (Routtenberg & Kuznesof, 1967).   
Likewise, Dwyer and Boakes found that ABA was indicated in rats that were 
allowed activity for 4 hours prior to the feeding period rather than those allowed activity 
for 18.5 hours after the feeding period.  The rats demonstrated corresponding running 
intensity except those who were allowed the 4-hour running time before the eating period 
reduced their food intake.  Therefore, it may seem essential to allow activity before 
feeding to obtain the ABA effect (Dwyer & Boakes, 1997).  Epling and Pierce suggested 
that running alone could cause a decrease in food intake and body weight, regardless of 
diet restriction.  They concluded that a severe reduction in food intake would only occur 
if activity “exponentially” increases; however, if activity remains stable or slightly 
increases, the amount of food consumed will eventually counterbalance the amount of 
energy expended (Epling & Pierce, 1988).  As mentioned previously, a study by Burden 
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demonstrated significant weight loss from running such that the experiment ended before 
the introduction to food restriction (Verna Rose Burden, 1992). 
 Housing conditions can also influence the outcomes of the ABA paradigm.  The 
effects of isolation and communal housing on self-starvation were studied.  Rats were 
restricted to 60 minutes of feeding and allowed 22.5 hours of activity before the meal 
period.  Half the animals in the communally housed groups “self-starved” (eating <1 
gram of food per day), but none of those in isolation did (Spatz & Jones, 1971).  Animals 
moved from individual housing to paired-housing showed a decrease in food intake as 
well (O'Connor & Eikelboom, 2000).  Conversely, other researchers found that 
individually housed animals are slower to adapt to the feeding schedule than the animals 
in the group-housing condition.  Additionally, rats that were previously housed 
communally and subsequently placed in isolation showed a higher decrease in body 
weight and a slower recovery rate than those that remained communally-housed (Boakes 
& Dwyer, 1997; Boakes et al., 1999). 
Pathology 
As mentioned earlier, activity-based anorexia can result in gastric ulcers.  In this 
situation, the procedure is referred to as the activity-stress (AS) ulcer paradigm 
(Manning, Wall, Montgomery, Simmons, & Sessions, 1978; Pare & Houser, 1973).  The 
AS paradigm involves restricting meal times to 30-60 minutes per day and allowing 
access to running wheels for the remainder of the day (Pare, 1975).  Similar to ABA, the 
animals will display high levels of activity and reduced food intake; however, they also 
develop glandular lesions that penetrate the muscularis mucosa of the gastric lining.  
More than half the animals constrained to this procedure die within 3-12 days.  Thus, this 
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paradigm has been suggested as a model for peptic ulcers in humans (Lambert, 1993; 
Manning et al., 1978).  Researchers studied the incidence of ulcerogenesis via other 
methods such as using shock (Murison & Olafsen, 1991) or restraint techniques (Brodie 
& Hanson, 1960; Politch & Herrenkohl, 1984); however, as acknowledged by Lambert, 
using diet restriction and allowing access to voluntary activity is the most realistic 
method if the results are to be compared with humans (Lambert, 1993).   
In a study previously mentioned, rats given a shorter acclimation period with 
access to food ad libitum produced the most ulcers when exposed to running wheels and 
a 1-hour restricted-feeding schedule compared to those allowed pre-adaptation to the 2-
hour restricted-feeding schedule (Pare et al., 1985).  Consistent with these results, a group 
of rats pre-adapted to a 1-hour feeding schedule ran faster than the group of rats deprived 
of the pre-adaptation period, yet the rats in the former group did not develop ulcers, while 
signs of ulcerations were seen in the latter group (Morrow & Garrick, 1993).  Tsuda and 
co-authors suggested that gastric disease would not occur if rats were given food ad 
libitum while exposed to the running wheels.  The incidence of gastric disease or 
ulcerogenesis would also diminish if rats were given access to running wheels with two 
30-minute feeding sessions rather than one 60-minute feeding session. (Tsuda, Tanaka, 
Iimori, Ida, & Nagasaki, 1981).   
In a study referenced earlier, when male and female rats were castrated and 
exposed to the AS paradigm, there was a significant difference in ulceration, with the 
castrated male rats having 5.9% of the corpus ulcerated compared to 3.4% ulceration in 
the castrated female rats (Lambert & Kinsley, 1993).  In other studies that examined the 
effects of gender, significant differences in weight loss between male and female rats 
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were found, although researchers did not find any sex differences in ulcer sensitivity 
when the animals were exposed to the AS paradigm (Doerries et al., 1991; Pare et al., 
1978). 
 Other tissues are also affected by a severe diet restriction and intensive exercise, 
including the thymus, spleen, and adrenal glands.  Hara and lab examined these organs as 
well as the lungs and stomachs after the experimental rats were exposed to either a 60-
minute daytime feeding schedule or to a 60-minute nighttime feeding schedule in 
combination with access to running wheels throughout the experiment.  Rats that were 
restricted to 60 minutes of feeding per day with no access to running wheels, and rats that 
had access to activity wheels while on ad libitum feeding, revealed no signs of stomach 
ulcers.  However, there were signs of ulcers for those rats that were restricted to food 
(night and daytime meals) and allowed access to running wheels.  Whereas the rats that 
were fed during the nighttime had a higher occurrence of ulcers compared to those who 
were fed during the daytime, the latter group died earlier (day 6) than the former group 
(day 10).  In addition, the thymus and spleen weights of the two groups were lower than 
normal, and the adrenal weights increased above normal.  The organ weights of the rats 
that were on a food-restricted diet with no access to activity wheels also changed 
considerably, although the changes were only minor compared to the rats that were food-
restricted and allowed access to activity.  There were reports of bleeding and 
inflammation of the thymuses as well as bleeding and congestion of the lungs for most of 
the experimental animals (Hara, Manabe, & Ogawa, 1981).   
In another experiment, the incidence of gastric ulcers and the changes in thymus 
and adrenal glands in male rats were examined.  Experimental subjects were assigned to 
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either an isolation- or group-reared condition (i.e., reared at 24-60 days old) and were 
introduced to one 90-minute feeding period per day with 22.5 hours of access to wheel 
activity.  Results showed a higher incidence of a 25% weight loss (57% versus 18%) in 
rats of the isolation-reared group.  There was an indication of slight atrophy of the 
thymus glands in the rats of the group-reared group.  However, researchers did not find 
any indication of gastric ulcers or any differences in the adrenal weights between the two 
groups (Ness et al., 1995).   
Hormones 
Another component to take into consideration is the regulation of hormonal 
secretion from endocrine glands as it is related to diet and stress.  It has been well 
indicated that stress, whether mental, physical, or any stimulant of the pituitary-adrenal 
axis, induces the secretion of corticotropin-releasing hormone (CRH).  Increased levels of 
CRH stimulate adrenocorticotrophic hormone (ACTH) release from the anterior pituitary 
glands, and elevated levels of ACTH ultimately stimulate the adrenal cortex for the 
production of cortisol or corticosterone, all of which are regulated via negative feedback 
inhibition.  However, in patients with anorexia nervosa, there is an increase in CRH and 
cortisol, however, the stimulation of ACTH from CRH is blunted because researchers 
found either normal levels or lower levels of ACTH in AN patients (Licinio, Wong, & 
Gold, 1996).   
Cortisol counteracts the roles of insulin by inhibiting the activation of glycogen 
synthase and the inhibition of glucose production and lipolysis (J. E. Hall & Adair, 1998).  
Past studies have shown that if cortisol levels are elevated food intake should be 
suppressed (Licinio et al., 1996; Rivier & Plotsky, 1986).  For example, the effects of 
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activity on food consumption in rats injected with either saline or alpha-helical 
corticotropin-releasing factor (CRF), which is a CRF antagonist, in the right lateral 
ventricle of the brain were studied.  Researchers found that increases in CRF levels were 
proportional to the risk of anorexia; that is, animals injected with saline and exposed to 
forced physical activity (i.e., 40min motor-driven treadmill) demonstrated slower growth 
and reduced food intake compared to those injected with saline without exposure to 
forced activity.  However, treatment with the CRF-antagonist prevented this anorexic 
effect probably by hindering the decrease in food consumption and bodyweight in 
exercising animals (Rivest & Richard, 1990). 
In addition, researchers have shown that underweight anorexic patients display 
elevated levels of CRH in the cerebrospinal fluid (CSF), which is then normalized after 
weight restoration (Kaye et al., 1987).  Similarly, anorexic patients show low responses 
to elevated plasma cortisol levels, yet demonstrated normalization of levels and responses 
after weight recovery.  In healthy individuals, high levels of cortisol signal negative 
feedback inhibition to decrease cortisol production and an increase in cortisol metabolism 
in order to normalize plasma levels.  Because the response (i.e., increased cortisol 
metabolism and decreased cortisol production) is not high in anorexic patients, the result 
is sustained hypercortisolism (Hotta et al., 1986).  Boyar and lab first reported that the 
hypercortisolism was an outcome of decreased cortisol metabolism (Boyar et al., 1977). 
Another study suggested that low weight and hyperactivity, which is normally 
seen in patients with anorexia, is not the primary causal factors in abnormal 
neuropeptides (e.g., cholecystokinin [CCK], CRH, neuropeptide Y [NPY], galanin 
[GAL], proopiomelanocortin [POMC]), rather food restriction is the principal contributor 
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(Wong, Licinio, Gold, & Glowa, 1993).  In this study, researchers measured the gene 
expression levels for CCK, CRH, and POMC, which decrease food intake and NPY and 
GAL, which increase food intake.  These neuropeptides are involved in the regulation of 
appetite and were measured in the paraventricular (PVN) and arcuate (ARC) areas of the 
brain (animals were killed 30 min after meal period).  Plasma measurements of ACTH 
and corticosterone were measured as well.  Food intake and bodyweight were also 
measured daily.  They found that although there were no significant differences in final 
food intake (experimental animals ate 9% less than their controls) and final body weight, 
there was a significant increase in ACTH and corticosterone in the experimental animals 
when compared to the controls.  There were no significant effects on the gene expression 
levels of CCK, CRH, NPY, GAL, and POMC.  Because food intake and body weight 
were not significantly different, it was suggested that activity did not have an effect on 
these neuropeptides even though it was associated with elevated levels of ACTH and 
corticosterone (Wong et al., 1993).  Thus, whether the increase in CRH/CRF (i.e., 
cortisol) level is the causal or the resulting factor or whether reduced food intake, 
decreased bodyweight, or hyperactivity, is the primary or secondary factor, it is well 
supported in several past experiments that there is a strong association between the 
elevation in cortisol levels and anorexia (Hotta et al., 1986; Kaye et al., 1987; Licinio et 
al., 1996; Rivest & Richard, 1990; Wong et al., 1993). 
Serotonin, also known as 5-hydroxytryptamine (5-HT), is another hormone that 
plays a role in feeding behavior.  Its receptors are widely found in the hypothalamus and 
in the gut, thus, alterations to the hypothalamus (e.g., lesions or drug injections) or 
modifications of the gastrointestinal tract (e.g., increases in intraluminal pressure or pH in 
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duodenum) can cause changes in eating behavior.  Serotonin has a specific effect on 
satiety rather than hunger signals (Blundell, 1977), thus, increases in serotonin levels are 
expected to decrease food consumption.  Scientists have developed anorectic drugs (e.g., 
fenfluramine and fluoxetine), which act on serotoninergic mechanisms to inhibit food 
intake, for the treatment of obesity (Carruba et al., 1986; Fessler, 2002; Rieg et al., 1994).  
However, the effects of elevated serotonin (5-HT) on food intake have shown conflicting 
results in one study.  For example, researchers found that increases in serotonin levels did 
result in a reduction in food intake (Carruba et al., 1986).  However, others have shown 
that low levels of serotonin levels were associated with a decreased food intake and that 
elevated serotonin levels resulted in a reduction in weight loss (Altemus, Glowa, 
Galliven, Leong, & Murphy, 1996).  In the former study, researchers demonstrated that 
subcutaneous injections of serotonin were strong enough to suppress food intake in 
hyperphagic-induced rats injected with insulin or 2-deoxy-D-glucose (2-DG).  In the 
latter study, researchers tested the effects of two drug treatments in rats:  fluoxetine, 
which improves serotonin activity, and parachlorophenylalanine (PCPA), which is a 
tryptophan hydroxylase inhibitor.  They found that rats treated with fluoxetine via 
intraperitoneal (IP) injections significantly lost less weight, showed less activity, and 
increased food consumption compared to saline-treated animals.  Animals treated with 
PCPA via IP injections demonstrated opposite results from fluoxetine-treated animals 
when compared to saline-treated animals (i.e., significantly lost more weight, showed 
more activity, and reduced food consumption).  Nevertheless, more evidence indicates 
that serotonin levels are inversely related to food intake and that anorexic individuals 
display lower than normal levels of 5-hydroxyindole acetic acid (5-HIAA), a serotonin 
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metabolite that has been found to be at above normal levels when patients have restored 
body weight (Rieg et al., 1994). 
Catecholamines (epinephrine [E], norepinephrine [NE], and dopamine [DA]) 
function in the promotion and regulation of energy metabolism.  E and NE are secreted 
by adrenal medulla in a 4:1 ratio, respectively.  The functions of E and NE include 
stimulation of adrenergic system, increase efficiency of muscular contraction, increase 
rate of glycogen breakdown into glucose, & increase rate of fatty acids (FA) release from 
fat.  Also, E (not NE) increases release of ACTH.  Because cortisol exerts permissive 
effects on the actions of catecholamines (E and NE), the catecholamines are not as 
effective as they are normally when cortisol levels are low (J. E. Hall & Adair, 1998).   
Exercise tends to increase plasma NE concentrations (Duncan et al., 1985; Kohno 
et al., 2000).  Additionally, DA plays a role in maintaining high levels of physical activity 
and suppressing food intake; thus contributing to the anorexic effects caused by the 
activity-stress model (Avraham, Hao, Mendelson, & Berry, 2001; Carruba et al., 1986; 
Lambert & Porter, 1992; Lyons & Truswell, 1988).  Researchers studied the effects of 
pimozide, a dopamine-D2-receptor blocker, in rats exposed to the activity-stress model 
and found that although it did not affect activity levels in the dark phase, it significantly 
reduced wheel running in the light phase resulting in an increase in number of surviving 
animals (Lambert & Porter, 1992).   
Diet and Metabolism 
Few studies have manipulated the diet in an attempt to attenuate the negative 
effects of deprivation and novelty stress in the activity-based anorexia paradigm.  For 
example, the effects of pellet-form and powder-form of food on body weight, food intake, 
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and level of activity were examined in one study.  Neither form of food eliminated 
starvation in rats; however, diet restriction and activity continued to affect the ABA 
outcomes.  Wheel access did not affect weight gain in those rats that had food available 
ad libitum, though, it did result in starvation of more than 75% of rats who were restricted 
of food and allowed access to wheels (Beneke et al., 1995).  
Researchers have studied the nutritional status of the individual or subject and the 
nutritional content of the diet as well.  Scientists have shown that tyrosine injections can 
prevent the activity-induced elevation of 5-HT levels in the hypothalamus thereby 
improving food consumption in rats exposed to the activity anorexia model.  The rats to 
be injected with tyrosine initially lost weight and decreased food intake when introduced 
to the activity anorexia model; however, despite the sustained increase in activity, food 
intake was returned to normal when compared to that of the saline-injected controls when 
tyrosine injections were administered (Avraham et al., 2001).  In addition, Davis and 
associates have suggested that carbohydrates (CHO) and branch-chained amino acids 
(BCAA) might prevent the activity-induced increase in 5-HT concentrations.  These 
researchers found that during prolonged exercises, fatigue was associated with elevated 
concentrations of 5-HT and a high ratio between 5-HT and dopamine levels; thus, 
lowering levels of 5-HT may decrease fatigue and sustain high energy levels (J. M. 
Davis, Alderson, & Welsh, 2000).  Furthermore, others have suggested that a high CHO 
meal should have greater effects on serotoninergic effects when compared to a low CHO 
meal since CHO have been shown to increase plasma tryptophan (Lyons & Truswell, 
1988). 
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In another experiment, researchers fed animals either a commercial lab diet 
containing 4.5% fat and 51% carbohydrates or an experimental diet that is high in fat 
(nearly 26% fat and no carbohydrates).  The rats that were fed the commercial diet ran 
five times more when restricted of food, and lost roughly 29% of their initial body 
weight, compared to the rats that were fed the high fat diet—the rats on the high fat diet 
increased their running at a much slower pace than those fed the commercial diet.  Ninety 
percent of the animals fed the high fat diet survived in contrast to only 20% of the rats fed 
the commercial diet.  It was suggested that the energy density of the high fat diet might 
help animals maintain a more normal body weight when exposed to the ABA model 
(Barboriak & Wilson, 1972).  A past study by Roy and lab demonstrated that rats fed a 
low-energy density diet increased food intake to increase energy consumption (H. J. Roy 
et al., 2003).  However, as mentioned above, the contents of the meal should not be the 
only factor to consider in ABA. 
The effect of carbohydrate metabolism on blood glucose levels (BGL) has been 
extensively studied especially in the study of hyperinsulinemia and insulin resistance.  
The transient hyper- and hypo-glycemic phase, which normally occurs hours after 
ingestion of a moderate to high carbohydrate meal, has been shown to signal many 
metabolic mechanisms (i.e., anabolism and catabolism of energy stores) that are assumed 
to play an important role in ABA (Ettinger, 2000; Winkler & Manchester, 2000).  Insulin 
and glucagon, both of which are secreted by the pancreas, are the two primary hormones 
functioning antagonistically to maintain euglycemia.  Insulin, which is released in 
response to high BGL, serves to lower BGL by promoting glucose uptake in cells, 
formation of fat (lipogenesis) and formation of glycogen (glycogenesis).  Glucagon, 
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which is released in response to low BGL or raised epinephrine levels, functions 
synergistically with epinephrine to raise BGL by stimulating the hydrolysis of stored 
glycogen (glycogenolysis) and fat (lipolysis) (J. E. Hall & Adair, 1998). 
Because impaired glucose tolerance (IGT) is frequently found in anorexic human 
individuals (Sheldon & Young, 1938; Silverman, 1977), the effects of plasma glucagon, 
glucose and insulin levels before and after dietary therapy and glucose challenges were 
studied.  Before treatment, researchers found that circulating plasma glucagon levels and 
plasma glucose levels were higher in AN subjects compared to the controls after the 
glucose meal; however, levels were suppressed after therapy.  Conversely, plasma insulin 
levels were lower in AN than those of the controls before and after the glucose meal and 
remained the same after the treatment.  It was concluded that IGT found in AN patients is 
possibly due to abnormalities in the secretion of insulin and glucagon from the pancreas, 
which does not completely regularize after diet therapy (Kumai, Tamai, Fujii, Nakagawa, 
& Aoki, 1988).   
Studies have shown that insulin-induced hypoglycemia, as well as 2-deoxy-D-
glucose, can raise feelings of hunger in humans (Silverstone & Besser, 1971; Thompson 
& Campbell, 1977).  2-deoxy-D-glucose (2-DG) is a glucose anti-metabolite or analogue 
that functions to inhibit glucose uptake and metabolism.  2-DG is known to induce 
hyperphagia in normal individuals (Frohman & Nagai, 1976); however, it has been 
shown to decrease hunger in anorexic human patients when compared to controls 
(Aravich, Stanley, & Doerries, 1995).  A study with humans suggested that the 
paradoxical response to 2-DG is not limited to those with anorexia nervosa.  The double-
blind study included six participants with anorexia (ranging from 51.4 to 68.4% IBW), 
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three participants with bulimia (106.3%, 100%, and 51.4% IBW), and six controls 
participants (ranging from 85.3% to 104.2% IBW).  The participants were infused with 
50mg of either 2-DG in saline or saline alone over 20 minutes.  For a total of three hours, 
participants evaluated their hunger and thirst ratings on a line scale 30 minutes before 
infusion and every 30 minutes after infusion.  Blood, blood pressure, pulse rate, and oral 
temperature were taken at those times as well.  Approximately 2.5 hours after the start of 
infusion, the participants were given a 20-minute lunch and a questionnaire to evaluate 
their judgment of satiety.  In the end, all the anorexic participants showed a decrease in 
hunger ratings after the 2-DG infusion.  Only the emaciated bulimic participant (51.4% 
IBW) showed the paradoxical effect of 2-DG while those of normal weight increased 
their hunger ratings (Nakai, Kinoshita, Koh, Tsujii, & Tsukada, 1987). 
 Consistent with the results reported for humans, in an animal study, rats were 
matched by weight and assigned to one of three experimental groups (deprived of food 
only, allowed access to wheels only, or exposed to both conditions) or the control group.  
When the animals lost 25% or more of their initial weight, they were randomly assigned 
to receive either a 2-DG or saline injection within two hours before the 6-hour feeding 
period and then decapitated.  The 2-DG injection caused significant reductions in food 
intake in both the ABA animals and the animals that lost weight due to food deprivation.  
It was proposed that 2-DG has a paradoxical effect for underweight individuals and does 
not affect those at a normal or above-normal body weight (Aravich et al., 1995). 
Furthermore, the effects of ABA on plasma glucose and insulin levels in animals 
administered 2-DG injections were examined.  The protocol was similar to the one 
described above, except that all the groups received 2-DG injections.  Results show that 
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weight changes were comparable to the previous experiment.  In addition, plasma glucose 
and insulin levels were reduced in ABA subjects and subjects deprived of food when 
injected with 2-DG before a meal.  Researchers concluded that the abnormal effects of 2-
DG on appetite, plasma glucose and plasma insulin levels, which all contribute to weight 
loss, that occur in this model are strongly comparable to anorexia nervosa in humans 
(Aravich et al., 1995).  Consistent with these results, Pare demonstrated that AS rats had 
a significant reduction in liver glycogen and serum glucose; therefore, they proposed that 
these results were due to “exhaustion of metabolic substrates (p.419)” (Pare, 1980).  
The theory of the glycemic index (GI) of foods first gained popularity in 1981 
(Berning, 2000; Brand-Miller, Nantel, Suma, & Lang, 2001).  GI represents the ratio of 
the area under the curve (AUC) of the blood glucose response curve over the first two 
hours of ingesting of a given quantity of the test CHO and AUC of the blood glucose 
response over the first two hours of consuming the same quantity of CHO from a 
standard food (e.g., white bread or glucose) (Vonk et al., 2000).  This ratio, or GI score, 
indicates the potential of the CHO to raise blood glucose levels after ingestion of that 
particular CHO.  Foods with a high GI have been shown to have a higher overall blood 
glucose response during the first 2 hours after meal consumption and an elevated 
secretion of insulin compared to foods with a low GI.   
About two decades ago, a diet/meal with a low glycemic index was found to be 
beneficial because it produces only a minimal rise in post-prandial glucose and insulin 
levels.  A high-GI diet/meal would have otherwise produced varying fluctuations in 
blood glucose and insulin levels and eventually low BGL in the late post-prandial period 
(Brand-Miller et al., 2001; Crapo, Insel, Sperling, & Kolterman, 1981; Febbraio, Keenan, 
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Angus, Campbell, & Garnham, 2000; Jenkins et al., 1987).  Low GI foods take longer to 
digest and absorb, thus, suppressing hepatic glucose and fatty acid production (Liljeberg, 
Akerberg, & Bjorck, 1999).  
In one study, healthy male human volunteers were assigned to an individualized 
low-GI diet (test 1) and a high-GI diet (test 2) for two 2-week testing periods.  The low-
GI diet consisted of 26g of fiber per 1000 kcal with a GI score of 64.  The high-GI diet 
contained 21g of fiber per 1000 kcal and had a GI score of 104.  Results showed that 
there was a 37% smaller rise in post-prandial BGL over 12 hours for the men on the low-
GI diet compared to the men on the high-GI diet.  In addition, insulin secretion, which 
was calculated from 24-hour urinary C-peptide measurements, was 32% lower in the 
low-GI diet.  At the end of the high-GI and low-GI periods, results from another standard 
test meal demonstrated higher blood glucose levels 45-minutes following the low-GI diet, 
although C-peptide levels remained low.  It was concluded that a low-GI diet has a 
positive effect on insulin secretions, and therefore CHO and lipid metabolism, in healthy 
male humans (Jenkins et al., 1987).  Likewise, in another study, a high GI meal produced 
higher post-prandial BGL, however, it also created lower BGL at the onset of exercise 
compared to a low GI meal despite no differences in exercise performance (Febbraio et 
al., 2000).  Conversely, other studies have shown a different effect (Brand-Miller et al., 
2001; Kirwan, Cyr-Campbell, Campbell, Scheiber, & Evans, 2001; Thomas, 
Brotherhood, & Brand, 1991).  In these trials, the low GI theory (i.e., the slow release of 
glucose into blood) has been shown to enhance physical performance, for example, by 
increasing exercise endurance if the meal was consumed 45 minutes to1 hour rather than 
3 hours prior to exercise (Brand-Miller et al., 2001).  Perhaps the difference between the 
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two studies is the method of measurement—the former study measured exercise 
performance within 120 minutes while the latter studies measured performance via a 
fatiguing concept (i.e., participants are evaluated based on the amount of time it takes to 
reach exhaustion). 
Recently, resistant starch (RS) has gained attention for possessing characteristics 
that are similar to dietary fiber, especially to that of soluble fiber.  It has been reported to 
produce BGL responses similar to that of low GI foods (Jenkins et al., 1987; Ring, Gee, 
Whittam, Orford, & Johnson, 1988).  RS, which is found at low amounts in many foods, 
is the form of starch that escapes the small intestine and is primarily fermented in the 
large intestine, which results in decreased post-prandial glucose and insulin response.  RS 
can be defined as “the sum of starch and products of starch hydrolysis not absorbed in the 
small intestine of healthy individuals (p. 23)” [from (Muir, Young, & O'Dea, 1994):  
European Concerted Action of Resistant Starch (EURESTA), June 1990].  RS has been 
categorized into four types:  RS1, RS2, RS3, and RS4; however, most interest has been 
directed to RS2 and RS3 (Muir et al., 1994).  RS2 is the ungelatinized starch granule, 
which is unavailable to digestible enzymes (e.g., amylase) due to its compact, unhydrated 
structure.  This type of RS can be found in cereals, legumes, raw potatoes, unripe 
bananas, or high amylose maize starch and is most commonly used in research.  RS3 
consists highly of crystalline amylose and amylopectin, which forms during starch 
retrogradation or recrystallizaton.  This type of RS can be found in bread or cooled boiled 
potatoes since it forms after the heating and later cooling of the food product (Haralampu, 
2000; Muir et al., 1994). 
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In an experiment that examined the digestion of resistant starch in the small 
intestine, researchers studied the metabolism of highly digestible cornstarch (DSC), 
Hylon VII (RS2) and Novelose 330 (RS3).  Twenty-one healthy human volunteers 
consumed 40g of glucose and one of the three starches after fasting for 10 hours.  
Measurements of plasma exogenous glucose concentrations and breath excretion of 
13CO2 are indirect indications of intestinal digestion.  Analysis revealed the highest 
response in breath hydrogen and exogenous glucose response levels after the DCS meal, 
primarily because of its high digestibility.  Average GI scores, which were determined 
after the intake of 40 grams of starch, were 98+138, 22+13, and 48+28 for DCS, Hylon 
VII and Novelose 330, respectively.  DCS was estimated to be 80% digestible in contrast 
to an approximate 50% digestibility of the resistant starches, with no differences between 
the two types (Vonk et al., 2000). 
Because resistant starch is fermented in the large intestine, the production of 
short-chained fatty acids (SCFA) (e.g., butyric, acetic, and propionic acids) may 
contribute to “total metabolizable energy” (Behall & Howe, 1996; Cummings & Englyst, 
1987; Ferguson, Tasman-Jones, Englyst, & Harris, 2000).  Twenty-four volunteers (ten 
controls and fourteen hyperinsulinemic participants) were fed individualized diets with 
the primary carbohydrate as either high amylose cornstarch (AM: containing 70% 
amylose, 30% amylopectin) or a standard cornstarch (AP:  containing 30% amylose, 70% 
amylopectin) for fourteen weeks.  Although results showed that the consumption of the 
AM diet resulted in increased fecal output and nitrogen, there were no differences in 
metabolizable energy between the two diets.  The results indicated that utilization of RS 
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provided energy for both the control participants (81.8% utilization) and for the 
hyperinsulinemic participants (53.2% utilization) (Behall & Howe, 1996). 
There are implications that resistant starch may have a positive effect for 
overweight, diabetic, hyperlipidemic, or cancerous individuals (Raben, Tagliabue et al., 
1994); (Muir et al., 1994).  Evidence have supported the idea that RS can help regulate 
the release of anabolic and catabolic hormones by producing minimal fluctuations in the 
blood glucose level after a meal (Byrnes, Miller, & Denyer, 1995; Hallfrisch & Behall, 
2000).  The slow absorption of RS in the small intestines of humans caused reductions in 
post-prandial glucose and insulin levels (Muir et al., 1994).  The effect on post-prandial 
plasma concentrations of glucose, lipids, and hormones in normal-weight, young males 
were studied. Participants were assigned either to a diet containing 54.1% RS (R-meal) or 
to one that is 100% digestible (S-meal) for two test periods.  Results showed that plasma 
glucose, lactate, insulin, GIP, and GLP-1 levels increased markedly after consumption of 
the S-meal compared to R-meal.  Plasma triglycerides decreased after both S-meals and 
R-meals.  Plasma glycerol also decreased after the S-meal, but remained reasonably 
constant after the R-meal.  Significant differences were not found in norepinephrine 
levels after both meals, but epinephrine levels increased after the S-meal (Raben, 
Tagliabue et al., 1994).  
Summary 
 In summary, in can be concluded that: 
1. Excessive exercising, diet restriction, and low body weight is strongly associated 
with anorexia. 
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2. The results of the activity-based anorexia model mimic the characteristics of 
individuals with anorexia nervosa. 
3. Animals exposed to the ABA procedure typically display reduced food intake and 
body weight, increased activity, elevation of corticosterone levels, hypertrophy of 
the adrenal glands, and atrophy of the thymus glands. 
4. Young animals weighing less than 250g (on average) are more prone to the ABA 
paradigm; however, it is controversial whether which gender is more vulnerable 
to the ABA model. 
5. Pre-adaptations to the feeding schedule or activity schedule, changes in the 
feeding duration, frequency, and time of day, and variations in the access to the 
running wheels can affect the ABA outcomes. 
6. Elevated levels of CRH, ACTH, corticosterone, epinephrine, norepinephrine, 
and/or dopamine may be associated with anorexia or cachexia. 
7. A high-fat diet provides protection for animals exposed to the ABA model 
compared to a normal commercial diet. 
8. Incorporation of resistant starch in the diet can result in significant reductions in 
post-prandial glycemia and insulinemia, therefore suppressing hepatic glucose 






MATERIALS AND METHODS 
The activity-based anorexia (ABA) animal model has clinical significance 
because many individuals with anorexia nervosa often use intense exercising and severe 
diet restriction as a means of losing weight and maintaining the weight loss (Kron et al., 
1978).  To our knowledge, only a few experiments have directly examined the effects of 
diet composition on activity-based anorexia.  Therefore, the proposed study was 
conducted in two experiments.  Experiment one was done to replicate the standard ABA 
procedure using a control diet (see Table 1).  Experiment two included resistant starch 
(RS2), which has a lower glycemic index, in the experimental diets (see Table 1) during 
exposure to the activity-based anorexia paradigm.  Resistant starches, which have 
recently gained interest for its similarity to dietary fiber, are glucose polymers that resist 
digestion by enzymes in the small intestines; consequently, the products of hydrolyzed 
starch are not readily absorbed in the small intestine.  Muir and associates demonstrated 
that the slow absorption of RS in the small intestines of humans caused reductions in 
post-prandial glucose and insulin (Muir et al., 1994).  Therefore, with the diet 
manipulation, it is predicted that the resistant starch diet will cause minimal rises in the 
blood glucose levels, thus, a slower, controlled release of anabolic and catabolic 
hormones (Byrnes et al., 1995; Hallfrisch & Behall, 2000; Raben, Tagliabue et al., 1994), 
and ultimately preserving the body’s energy stores and reducing weight loss.   
General Materials and Procedures 
Animals.  Sprague-Dawley male rats were purchased from Harlan Bioproducts 
for Science, Inc. (Indianapolis, IN).  They were maintained on a 12-hour light/dark cycle 
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Table 1.  Diet Composition1:  Percent of Diet and Caloric Breakdown 
Ingredients Experiment 1 Experiment 2 
 Control Diet Control Diet Resistant Starch 
Diet 
 Percent2 Kcal3 Percent2 Kcal3 Percent2 Kcal3 
Amylopectin 
Cornstarch4  




-- -- -- -- 33.3 0.52 
Casein6  
 
20.0 0.72 20.0 0.72 20.0 0.72 
Sucrose6 
 
10.0 0.40 10.0 0.40 10.0 0.40 
Cellulose6 
 
5.0 0.00 5.0 0.00 5.0 0.00 
Mineral Mix 
(AIN-93G) 1,6 
3.5 0.03 3.5 0.03 3.5 0.03 
Vitamin Mix 
(AIN-93G) 1,6 
1.0 0.04 1.0 0.04 1.0 0.04 
Choline 
Bitartrate6 
0.3 0.00 -- -- -- -- 
Choline 
Chloride6 
-- -- 0.1 0.00 0.1 0.00 
L-Cystine6 
 
0.3 0.01 0.3 0.01 0.3 0.01 
Soybean Oil7 
 
14.0 1.26 7.0 0.63 7.0 0.63 
BHT6, 8 
  
0.001  0.001  0.001  
Kcal/g Food  4.11  3.74  3.05 
 
1 AIN-93G (Reeves, Nielsen, & Fahey, 1993) 
2 All values are in percent of diet 
3 All values are in kcal per g food 
4 High Amylopectin starch (100% amylopectin), (Cerestar, Hammond, IN), (3.5kcal/g) 
5 Hi-Maize (60% amylose, 40% amylopectin), (Renford, Plover, WI), (estimated as 
1.65 kcal/g) 
6 Sucrose was attained from Thrifty Maid (Sun Mateo, CA) and Casein, Cellulose, 
Mineral Mix AIN-93G, Vitamin Mix AIN-93G, Choline Bitartrate, Choline Chloride, 
L-Cystine, and BHT were attained from Dyets (Bethesda, PA), which also provided 
energy values of diet ingredients.  
7 Soybean oil (Aster) was attained from Deep South Products. 
80.015% of Butylated Hydroxytoluene (BHT) was mixed in soybean oil 
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in a temperature-controlled room (22-25 degrees Celsius) that was automatically 
illuminated at 7AM-7PM.  Water was available ad libitum throughout the experiment.  
Unlimited access to powdered food was available to all the animals throughout the 
acclimation period and to specified groups (see below) during the experimental period.  
All diets were modified versions of the American Institute of Nutrition-93-Growing diet 
(AIN-93G) (Reeves et al., 1993).  The compositions of the diets are shown in Table 1.  
The different diets and feeding schedules are described in further details below.   
Apparatus.  All the animals in experiment one were housed in Columbus 
Instruments Mechanical Activity Monitor Wheels (Columbus, OH), which are made of 
stainless steel and Plexiglas.  The wheel, which has a mesh running surface and measures 
14” in diameter and 4” in width, is connected to a mechanical counter that records the 
number of complete wheel revolutions in either direction.  Adjacent to the wheel, but 
separated by a sliding door, is a 10”x 6”x 5” mesh wired-bottom cage for which the 
animal has access to food and water.  The sliding door was manually opened and closed 
by the experimenter.  A water bottle is mounted on the side of the cage with the 
mouthpiece inserted through a mesh hole, and a food cup is secured within the cage by 
wired springs.  In experiment two, half the animals were housed in the Columbus 
Instruments Mechanical Activity Monitor Wheels (as used in experiment one), and the 
other half were housed in standard 8”x 10”x 7” hanging stainless steel cages with wired 
bottoms.  Those housed in the hanging steel cages received water via a watering system 
and those housed in the mechanical wheels received water via water bottles (see below 
for details on housing).  All food cups are secured within the cages by wired springs in 
both housing environments. 
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General Procedures.  Upon arrival in the laboratory, the animals were 
acclimatized to the environment, and food and water were available ad libitum 
throughout this period.  A run-test, which is an assessment of spontaneous activity, was 
administered in order to eliminate abnormally low- and high- level runners (details 
below).  Epling and Pierce selected the “most active” animals and assigned them to the 
running groups (Epling & Pierce, 1984).  However, to avoid unusually low or high 
activity, assignment to running groups was determined by selecting half the animals with 
the total number of wheel revolutions nearest to the mean number of total wheel 
revolutions during the run-test.  The chosen animals were stratified by the results from 
the run-test and by their current weight and then randomly assigned into one of the 
running groups.  The remaining animals were stratified by their current weight and 
randomized into one of the groups with no access to running wheels.   
During the experimental period, the animals followed their specified feeding and 
activity schedules (more details below).  Wheel rotations for the individual running 
animals were recorded daily and all the animals were weighed everyday.  Throughout the 
run-test and experimental periods, the animals were not restricted to the wheels in order 
to avoid forcing activity upon the animals.  Measurements for food intake were taken 
immediately before and after the feeding period for animals on a restricted feeding 
schedule by weighing the food cups and food spillage daily; however, measurements for 
animals on an ad libitum feeding schedule were taken every other day.  Food spilled from 
the food cups of all animals were weighed and recorded.  Food was replenished at least 
every other day and water bottles were changed daily.  The experiment ended when the 
majority of the animals in the ABA group (i.e., animals subjected to restricted feeding 
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and liberal activity) have met one of the two criteria.  The animals were considered to 
reach the anorexia criteria when the majority of the animals from the ABA group reached 
75% or less of their pre-experimental body weight for 2-consecutive days.  However, the 
animals were considered to reach the recovery criteria when the majority of the animals 
from the ABA group have stabilized their weight.  That is, when the animal’s weight on 
day 4 is at or above its weight on day 1 in any consecutive-4-day period.  Due to the large 
number of animals, the termination period took place on two consecutive days.  On the 
day of the kill, all animals chosen for decapitation are weighed at 4PM and tissue 
collections began at 4:30PM.   Tissues and fat pads were rapidly excised, examined, and 
weighed.  Livers were immediately frozen in liquid nitrogen and the brains were frozen 
on dry ice.  Trunk blood was collected and immediately placed on ice.  All samples were 
kept in –80°C until needed for analyses.  
Experiment One (2x2 Factorial Design) 
In this experiment, twenty-eight 4-week old male Sprague-Dawley rats were 
maintained on a 12-hour light/dark cycle (automatically illuminated at 7AM-7PM).  All 
the animals were fed a 14% fat, high-GI (Control) diet throughout the experiment (see 
Table 1).  Upon arrival in the laboratory, the animals were assigned to wheel cages with 
the passage to the wheels locked.  The animals were acclimated for approximately one 
week (day -8 to day –1), throughout which water and food were fed ad libitum and access 
to activity wheels was not allowed.  The acclimation period occurred in the same room as 
the experimental period.  During acclimation, all the animals were subjected to a run-test.  
Because there were a limited number of wheels that were functioning properly, the run-
test was divided into two days.  Half the animals (n=14) were tested on day -6 at 
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1:30PM-3:30PM (100% light) and the other half (n=14) were tested on day -5 at 1:00PM-
3:30PM (100% light).  As described earlier, the animals were assigned to the running 
groups by selecting half the animals with the total number of wheel revolutions nearest to 
the mean number of total wheel revolutions during the run-test.  The chosen animals were 
stratified by the results from the run-test and by their current weight and then randomly 
assigned into one of the running groups.  The remaining animals were stratified by their 
current weight and randomized into one of the groups with no access to running wheels.  
The four groups consisted of two running groups (R/RF, R/AL) and two non-running 
groups (NR/RF, NR/AL).  One active group and one inactive group were fed ad libitum 
(R/AL, NR/AL) while the other two groups were on a restricted feeding schedule (R/RF, 











At the start of the experimental period (day 0 at 6PM), the doors to the running 












7 (R/RF)  
Figure 1.  Experiment One (n=28) 
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activity wheels and the food was removed from the appropriate animals (R/RF, NR/RF).  
From day 1 onward (see Figure 2), the restricted-fed animals were allowed one 90-minute 
meal period daily (4:30PM-6PM; 100% light cycle), which preceded the dark cycle, and 
the running animals were allowed 22 hours of activity (6PM-4PM; 55% dark/45% light 
cycle) immediately after the meal period.  Total wheel revolutions were recorded daily at 
exactly 4PM, and body weights were taken during the 30-minute transition time (4PM-
4:30PM), which occurred after physical activity but before the meal period.  Food intake 
measurements were taken at least every other day throughout the experiment.   
The experimental period terminated when the majority of the animals from the 
R/RF group reached the recovery criteria, that is, their weights on day 4 was at or above 
their weights on day 1 in a consecutive 4-day period.  Blood glucose levels were 
measured at the time of decapitation; glucose levels were measured using the Advantage 
Accucheck glucose meter from Roche Diagnostics (Indianapolis, IN).  Trunk blood was 
collected for measurements of plasma catecholamines, corticosterone, insulin, and 
glucagon levels.  Burden and co-authors showed an increase in corticosterone levels in 
experimental animals; however, they found norepinephrine levels to be consistent among 
all groups (V. R. Burden et al., 1993).  Also, the insulin and glucose levels were 
significantly lower in animals exposed to both running and food-restricted conditions 
compared to the controls.  Abdominal, perirenal, and epididymal fats, as well as brown 
fats, were removed and weighed.  A past study (V. R. Burden et al., 1993) demonstrated 
that animals exposed to running wheels and restricted to one daily meal lost up to 52% 
body fat compared to those only food-restricted.  The thymus, livers, spleens, kidneys, 
and adrenal glands were also removed, weighed, and examined for abnormalities.  
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Figure 2.  Daily Schedule for Animals (Experiment 1 & 2) 
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Studies have found a decrease in thymus and spleen weights and an increase in adrenal 
weights in ABA animals compared to the controls (V. R. Burden et al., 1993; Hara et al., 
1981).  Stomachs were removed, weighed, and examined for ulcers.  The protocol was 
submitted to and approved by the Institutional Animal Care and Use Committee 
(IACUC) of Louisiana State University A& M College in Baton Rouge, Louisiana 
(Appendix A & B).    
Experiment Two (2x2x2 Factorial Design) 
The model used in this experiment followed the method as described above, 
however, there were a few modifications.  In this experiment, fifty-six 4-week old male 
Sprague-Dawley rats were maintained on a 12-hour light/dark cycle (automatically 
illuminated at 7AM-7PM).  Upon arrival (day -7) to the facility, the animals were 
randomized into the two different diet groups (see Table 1) and were fed the specified 
diet throughout the acclimation period, which lasted one week (day –7 to day -1), and the 
experimental period.  All the animals were individually housed in standard hanging steel 
cages (as described previously) in a quarantine room for the first 5 days of acclimation 
(days -7 to –2) and were given water and food ad libitum.  The animals were then 
transferred to the experimental animal room on day -2, and all animals remained in the 
standard cages until the start of the experiment (day 0) or unless otherwise stated below.  
Both the quarantine and experimental rooms were temperature-controlled and 
automatically illuminated at 7AM-7PM.   
On the first day the rats were transferred to the experimental room (day -2), 28 
rats (14 rats from the Control group and 14 rats from the RS group) were randomly 
selected for the first run-test.  Unlike experiment one, this test allowed the rats access to 
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running wheels for 14 continuous hours, which consisted of 2 hours in the light cycle 
(5PM-7PM) and 12 hours in the dark cycle (7PM-7AM).  The rats were transferred to 
wheel cages during the test and were returned to their standard cages when testing was 
not in session.  At 4:30PM, the rats were transferred to the wheel cages (with their 
specified food and water) and the passages to the wheels were opened at 5:00PM.  On the 
following day (day-1), the passage doors to the wheels were closed at 7AM and the rats 
were immediately returned to their previous cages.  The same procedure followed for the 
second half of the animals on this day (day -1).   
As in experiment one, the animals were assigned to the running groups by 
selecting half the animals with the total number of wheel revolutions nearest to the mean 
number of total wheel revolutions during the run-test.  The chosen animals were stratified 
by the results from the run-test and by their current weight and then randomly assigned 
into one of the running groups within the diet group.  The remaining animals were 
stratified by their current weight and randomized into one of the groups with no access to 
running wheels within the diet group.  Because the animals were acclimated on a 
specified diet and needed to remain on the diet for the remainder of the experiment, they 
were stratified and randomized within their own diet group.  The eight groups in this 
experiment consisted of four running groups (R/AL, R/RF, rsR/AL, rsR/RF) and four 
non-running groups (NR/AL, NR/RF, rsNR/AL, rsNR/RF).  Two active groups and two 
inactive groups were fed ad libitum (NR/AL, R/AL, rsNR/AL, rsR/AL) while the 
remaining four groups were on a restricted feeding schedule (NR/RF, R/RF, rsNR/RF, 
rsR/RF).  The animals were also fed one of two different diets.  Four groups (NR/AL,
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NR/RF, R/AL, R/RF) were fed a high-GI diet containing regular cornstarch (7% fat, 
Control) and the other four (rsNR/AL, rsNR/RF, rsR/AL, rsR/RF) were fed a low-GI diet 
containing resistant starch (7% fat, RS) diet (see Table 1 and Figure 3).  After the 
assignment of groups, the animals were then transferred to their appropriate cages for the 















On the first day of the experiment (day 0), all animals were placed in either the 
standard cages or wheel cages according to their assigned group at 4PM and the daily 
routine for all 8 groups followed the same procedures as in experiment one.  At exactly 



























Figure 3.  Experiment Two (n=56) 
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restricted feeding schedule (NR/RF, R/RF, rsNR/RF, rsR/RF), and passages to wheels 
were allowed for those allowed physical activity (R/AL, R/RF, rsR/AL, rsR/RF).  Food 
was also replenished, weighed and given to those on an ad libitum diet schedule (NR/AL, 
R/AL, rsNR/AL, rsR/AL) at this time.   
The experiment terminated on day 5 when majority of the animals in rsR/RF 
group reached the anorexia criteria, that is, they experienced 25% weight loss from pre-
experimental body weight.  The termination period followed similar procedures as 
experiment one, however, there were a few changes.  One, stomachs were collected 
without emptying and examining for irregularities; thus, we will eliminate stomach data 
all together.  Two, blood serum was collected for two animals that were killed earlier that 
day (11AM) and blood plasma were collected for the other 53 animals killed later that 
day and the following day, however, this will not affect certain humoral analysis.  Three, 
rather than using a glucose meter to measure blood glucose levels at time of death as in 
experiment one, plasma and serum glucose levels were determined by using the 
Infinity Glucose Hexokinase Liquid Stable Reagent.  Four, retroperitoneal fat pads 
rather than abdominal fat pads were removed and weighed.   
Our past experiments have found that non-fasting plasma insulin levels are lower 
in animals fed the RS diet compared to the controls, and abdominal, perirenal, and brown 
fat pad weights are decreased in animals fed the RS diet.  Epididymal fat pad weights 
have also been shown to decrease with a RS diet (Kishida, Nogami, Himeno, & Ebihara, 
2001; Pawlak, Bryson, Denyer, & Brand-Miller, 2001).  The protocol was submitted to 
and approved by the Institutional Animal Care and Use Committee (IACUC) of 
Pennington Biomedical Research Center in Baton Rouge, Louisiana (Appendix C & D).  
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Humoral Analysis 
 Trunk blood was collected in 4 mL BD Vacutainer Plus tubes spray-dried with 
K2 EDTA with Hemogard Closures for plasma collection (Becker, Dickinson & Co., 
Franklin Lakes, NJ) and 13 mL standard test tubes for serum collection at decapitation.  
Samples were immediately placed on ice and later centrifuged at 4000 rpm at 4°C for 20 
minutes.  Plasma and serum samples were stored at –80°C until use for analyses.  
Catecholamine Measurements.  Plasma epinephrine and norepinephrine were 
determined by using a reverse-phase high-performance liquid chromatography with 
electrochemical detection (HPLC-EC).  The HPLC-EC system operated with the 
Coulochem II Model 5600A detector, Solvent Delivery Module Model 582 pump, Guard 
Cell with single channel Model 5020, and Autosampler Model 542.  The solvent, which 
contained methanol, phosphate buffer, and ion-pairing agent, used in this system was 
provided in the analysis kit [solvent:  CAT-A-PAHSE #45-0180; Kit:  Plasma 
Catecholamine Analysis Kit (ESA Inc., Chelmsford, MA)].  The method for 
catecholamine measurement was performed as described in the methodology booklet 
included with the kit.  The CoulArray Software (version 1.04) was used to analyze the 
data.  All samples were analyzed in dup licates. 
RIA Measurements.  Radioimmunoassay (RIA) kits were used to determine 
plasma and serum levels of glucagon (Glucagon RIA Kit, LINCO Research Inc., St. 
Charles, MO), insulin (Sensitive Rat Insulin RIA Kit, LINCO Research Inc., St. Charles, 
MO) and corticosterone (ImmuChem Double Antibody Corticosterone 125I RIA Kit, 
ICN Biomedicals, Inc., Costa Mesa, CA).  The procedures for glucagon, insulin, and 
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corticosterone measurements were performed as described in the methodology booklet 
included with the kits.  All samples were performed in duplicates. 
Plasma Glucose Measurements.  Plasma and serum glucose was measured with 
the Infinity Glucose Hexokinase Liquid Stable Reagent (Thermo DMA, Louisville, 
CO).  The procedure for glucose measurement was performed as described in the 
methodology booklet included with the package, however, a microplate reading 
instrument was used to analyze multiple samples rather than an individual sample during 
one reading.  Although the incubation time ranged from 5-25 minutes across all samples 
and standards, the reaction was stable because Glucose Hexokinase reagents have a final 
reaction mixture stability of approximately 30 minutes.  In addition, linear standards were 
used to control for the possibility in variation due to the large incubation time range.  The 
samples were measured in duplicates (i.e., one of each sample per plate). 
Statistical Analysis 
Data were analyzed using Statistical Analysis Software version 8.2 (SAS).  Means 
+ standard error means (+SEM) of all variables were computed for each of the groups.  
Repeated measurements of variance were used for daily wheel running with day as the 
repeated measure.  One-way analysis of variance (ANOVA) was performed on all other 
factors as well as cumulative wheel running to determine whether there were significant 
main effects of treatment among all the groups.  Observed results were considered 
statistically significant if the probability of chance occurrence was p<0 .05.  When one-
way ANOVA indicated statistical significance, a post-hoc Tukey’s Test was used to 





The results of experiment one were flawed due to uncontrollable environmental 
conditions and inefficient supervision of laboratory systems (see Appendix E for further 
explanation); therefore, experiment one and the results of experiment one will not be 
mentioned hereafter.  The results presented below will represent only that of experiment 
two.   
Body Weight 
Tables 2, 3 and 4 provide data for the average total change in body weight 
(+SEM) from day 0 to last day of the study.  There were no significant differences in 
initial body weights among the eight treatment groups at the beginning of the study (data 
not shown; p>0.05).  However, by the end of the study, there was a significant difference 
in body weight between diet groups, between feeding groups, and between activity 
groups as well as a significant diet*feeding interaction.  As illustrated in Figure 4, 
animals fed the resistant starch (RS) diet had lower body weights than those fed the 
control (C) diet (p=0.002) throughout most of the study period.  The animals on the 
restricted feeding (RF) schedule lost weight while the animals fed ad libitum (AL) gained 
weight by the end of the study (p<0.0001) (Tables 2 and 3).  Likewise, the exercising 
animals lost weight and the sedentary animals gained weight by the end of the study 
(p=0.001) (Tables 2 and 3).  Lastly, as shown in Figure 5, AL animals fed the RS-diet 
gained approximately the same amount of body weight as the AL animals fed the C-diet; 




Ad Libitum Feeding.  Table 2 provides data on caloric intake and food intake 
expressed as mean cumulative (day 0-4) kilocalories (kcal) per kilogram (kg) of body 
weight (+SEM) and mean cumulative (day 0-4) grams (g) per kg of body weight (+SEM), 
respectively, for AL animals.  On day 0-1, diet and activity had a significant main effect 
on caloric intake for AL animals (data not shown).  Animals fed the RS-diet consumed 
15% less kilocalories than those fed the C-diet (p=0.002).  Exercising animals consumed 
12% fewer kilocalories than the sedentary animals (p=0.008).  However, on day 0-1, only 
activity had a significant main effect on food intake (data not shown).  Exercising 
animals consumed 12% less food than the sedentary animals (p=0.01). 
On day 3-4, diet and activity continued to have a significant main effect on caloric 
intake for AL animals (Table 2).  Animals fed the RS-diet still consumed 15% less 
kilocalories than those fed the C-diet (p<0.0001); however, exercising animals only 
consumed 8% fewer kilocalories than the sedentary animals (p=0.03).  Nevertheless, diet 
did not have a main effect on food intake, as did activity (Table 2).  Exercising animals 
consumed nearly 8% less food when compared to sedentary animals (p=0.02). 
Restricted Feeding.  Table 3 provides information for caloric intake and food 
intake expressed as mean cumulative (day 0-4) kcal/kg of body weight (+SEM) and mean 
cumulative (day 0-4) g/kg of body weight (+SEM), respectively, for RF animals.  On day 
1, diet and activity did not have a significant main effect on food consumption (kcal and 
grams) for RF animals (data not shown).  However, on day 4, there were significant main 
effects of diet and activity as well as a significant diet*activity interaction for caloric 
intake in animals on the RF schedule.  Animals fed the RS-diet consumed 16% fewer 
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 Ad Libitum 
 Control Resistant Starch 




42.1 + 2.3 30.3 + 2.3
 




395 + 10a 347 + 12b
 




1486 + 44a 1312 + 48a,b
 
1202 + 38b 1162 + 54b
 
Note:  Total body weight change represents weight change from day 0 to day of kill; 
cumulative data represents day 0 to day 4 (thereafter, inanition interferes with accuracy of 
representation); values are expressed as mean + SEM; significant differences at p<0.05 





 Restricted Feeding 
 Control Resistant Starch 




(16.5) + 3.1a (30.8) + 3.3a
 




167 + 12a,b 178 + 10a,b
 




625 + 44a 636 + 22a
 
616 + 42a 444 + 30b
 
Note:  Total body weight change represents weight change from day 0 to day of kill; 
cumulative data represents day 0 to day 4 (thereafter, inanition interferes with accuracy of 
representation); values are expressed as mean + SEM; ( ) indicates weight loss; 
significant differences at p<0.05 are indicated by a, b (Tukey-Kramer Test); n=7 unless 
otherwise specified; *n=6 
 
Table 2.  Body Weight Change and Cumulative Food Intake (Ad Libitum) 





 Control Resistant Starch 
















1312 + 48a 636 + 22b 1162 + 54a 444 + 30c
 
Note:  Total body weight change represents weight change from day 0 to day of kill; 
cumulative data represents day 0 to day 4 (thereafter, inanition interferes with accuracy of 
representation); values are expressed as mean + SEM; ( ) indicates weight loss; 
significant differences at p<0.05 are indicated by a, b, c (Tukey-Kramer Test); n=7 unless 
otherwise specified; *n=6 
 
 
kilocalories than those fed the C-diet (p=0.01).  Exercising animals consumed 
approximately 13% fewer kilocalories than the sedentary animals (p=0.03).  As 
demonstrated in Figure 6, there were no significant differences between sedentary and 
exercising animals fed the C-diet (p=1.0).  However, exercising animals fed the RS-diet 
consumed 28% less kilocalories than the sedentary animals (p=0.02).  Exercising animals 
fed the C-diet ate approximately 30% more kilocalories than the exercising animals fed 
the RS-diet (p=0.004).   
On the other hand, there was only a significant main effect of activity and a 
significant diet*activity interaction for food intake for animals on the RF schedule.  
Table 4.  Body Weight Change, Cumulative Wheel Running, and Cumulative 

















Exercising animals consumed 13% less food than the sedentary animals (p=0.04).  As 
shown in Figure 7, there were no differences in food intake between sedentary and 
exercising animals fed the C-diet (p=0.9); however, exercising animals fed the RS-diet 
ate roughly 29% less food than the sedentary animals (p=0.006).  There were no 
differences of food consumption between ABA animals of each diet group (p=0.21). 
Activity.  Table 4 provides information for caloric intake and food intake in mean 
cumulative (day 0-4) kcal/kg of body weight (+SEM) and mean cumulative (day 0-4) 


















Figure 4. Daily Body Weight (Control vs. Resistant Starch diet) 
Note: C=control diet; RS=resistant starch diet; day 0 represents the start of the 

















were significant main effects of diet and feeding schedule on caloric intake for exercising 
animals.  Animals fed the RS-diet consumed 18% less kilocalories than those fed the C-
diet (p=0.0003).  Also, animals on the RF schedule consumed 56% fewer kilocalories 
than those AL-fed (p<0.0001). 
Additionally, on day 3-4, there was a significant main effect of feeding and a 
significant diet*feeding effect on food intake for exercising animals.  Animals on the RF 
schedule consumed 56% less food than those AL-fed (p<0.0001).  As shown in Figure 8, 
AL-fed animals fed the C-diet consumed 10% less food than AL-fed animals fed the RS- 




















Figure 5. Total Body Weight Change (Diet x Feeding) 
Note: C=control diet, RS=resistant starch diet; significant differences (Tukey-



















diet; however, RF animals fed the C-diet consumed 18% more food than RF animals of 
the RS-diet (p=0.009). 
Wheel Running 
 Table 4 provides information for the average cumulative wheel running 
revolutions (+SEM) from day 0 to day 4 of the study.  Throughout the study period, there 
was a significant main effect of diet and feed on wheel running.  On day 0-1, animals fed 
the RS-diet ran 1.4x more than those fed the C-diet (p=0.005) (Figure 9a).  Also, RF  




















Figure 6. Cumulative Food Intake for RF in kcal/kg (diet x activity) 
Note: C=control diet, RS=resistant starch diet, RF=restricted feeding; significant 
differences (Tukey-Kramer Test; p<0.05) are represented by A and B; this 
illustration represent animals on the restricted feeding schedule; values are 
















animals ran 1.4x more than those fed AL (p=0.005) (Figure 9b).  By day 3-4, animals fed 
the RS-diet continued to run approximately 1.4x more (daily and cumulatively) than 
those fed the C-diet (p=0.03)  (Figure 9a); however, the animals on the RF schedule ran 
2.6x more (daily and cumulatively) than those fed AL (p<0.0001) (Figure 9b).   
Figure 10 illustrates the running pattern for days 0-4 that the animals 
demonstrated during the study period.  By day 3-4, the animals on the AL feeding 
schedule of both the RS-diet and C-diet did not significantly increase their daily activity 
since day 0-1 (p=1.00); however, animals on the RF schedule in both diets increased their 
daily wheel running significantly when compared to activity on day 0-1 (p<0.05), with 
Figure 7. Cumulative Food Intake for RF in g/kg (diet x activity) 
Note: C=control diet, RS=resistant starch diet, RF= restricted feeding; significant 
differences (Tukey-Kramer Test; p<0.05) are represented by A and B; this 
illustration represent animals on the restricted feeding schedule; values are 
expressed as mean cumulative g/kg + SEM 
































the ABA animals fed the C-diet and RS-diet significantly increasing their activity as early 
as day 2-3 and 1-2, respectively (p=0.002 and p<0.0001). 
Tissue Weights and Fat Pad Weights 
 Thymus, Spleen, and Liver.  Tables 5 and 6 provide data of the mean weights 
(+SEM) for thymus, spleen, and liver expressed in grams per kilogram of body weight.  
There was a significant main effect of diet, feeding schedule, and activity on the thymus, 
spleen, and liver weights.  Animals fed the RS-diet had 1.3x, 1.2x, and 1.2x lower 
thymus, spleen, and liver weights, respectively, compared to the animals fed the control 
diet (p<0.0001).  The RF schedule decreased the thymus, spleen, and liver weights by 
2.3x, 1.7x, and 1.4x, respectively, compared to the animals fed ad libitum (p<0.0001).   
Figure 8. Cumulative Food Intake for Runners in g/kg (diet x feeding) 
Note: C=control diet, RS=resistant starch diet; significant differences (Tukey-
Kramer Test; p<0.05) are represented by A and B; this illustration represents 
exercising animals; values are expressed as mean cumulative g/kg + SEM 




















































Figure 9a. Daily Wheel Revolutions (C vs. RS) 
Figure 9b.  Daily Wheel Revolutions (AL vs. RF) 
Note: C=control diet, RS=resistant starch diet, AL=ad libitum, RF=restricted 
feeding; this figure represents mean daily wheel revolutions + SEM rather than 
cumulative running (see Table 4 for cumulative running data) 
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Exercising animals had 1.2x, 1.1x, and 1.1x lower thymus, spleen, and liver weights, 
respectively, compared to the sedentary animals (p=0.002, p=0.003, p=0.039, 
respectively). 
In addition, there was a significant diet*feeding (p=0.002), activity*feeding 
(p=0.003), and diet*feeding*activity (p=0.009) interaction for thymus weights.  RF 
animals fed the C-diet had 1.8x lower thymus weights than those AL-fed; however, the 
RF animals fed the RS-diet had 3.2x lower thymus weights than those AL-fed.  In 
animals fed AL, exercising did not greatly affect the thymus weights when compared to 
Figure 10. Daily Wheel Revolutions  
Note: c=control diet, rs=resistant starch diet, AL=ad libitum, RF=restricted feeding; 
this figure represents mean daily wheel revolutions + SEM rather than cumulative 































 Ad Libitum 
 Control Resistant Starch 
 Non-Runners Runners Non-Runners Runners 
Thymus 3.3 + 0.2 3.4 + 0.2 3.3 + 0.2 3.1 + 0.2
Spleen 3.2 + 0.1 3.3 + 0.1 3.1 + 0.1 3.1 + 0.2
Liver 38.4 + 1.4 37.3 + 0.8 34.0 + 0.9 34.9 + 1.0
Kidneys 7.9 + 0.1 7.9 + 0.2 7.7 + 0.2 7.6 + 0.2
Adrenal Glands 0.19 + 0.03 0.19 + 0.01 0.17 + 0.02 0.22 + 0.02
Retroperitoneal 
Fat 
1.69 + 0.35a 0.80 + 0.16a,b 1.08 + 0.15a,b 0.40 + 0.10b
Epididymal Fat 6.84 + 0.55a 4.86 + 0.28b,c 5.58 + 0.34a,b 3.45 + 0.54c
Perirenal Fat 1.25 + 0.14a 0.93 + 0.07a,b 0.98 + 0.07a,b 0.69 + 0.03b
Brown Fat 1.57 + 0.14 1.63 + 0.08 1.40 + 0.08 1.46 + 0.07
 
Note:  Values are expressed as mean g/kg + SEM; significant differences at p<0.05 




the sedentary animals (3.24g/kg vs. 3.27g/kg, respectively); conversely, in RF animals, 
exercising animals had 1.65x lower thymus weights than the sedentary animals.  In 
exercising animals on the RF schedule, those fed the C-diet had 2.5x lower thymus 
weights than their sedentary AL-fed controls and those fed the RS-diet had 3.8x lower 
thymus weights than their sedentary AL-fed animals.  Furthermore, in sedentary animals, 
animals on the RF schedule and fed the C-diet had only 1.3x lower thymus weights than 
the sedentary AL-fed animals, while animals on the RF schedule and fed the RS-diet had 
Table 5.  Tissues and Fat Pad Weights (Ad Libitum) 
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 Restricted Feeding 
 Control Resistant Starch 
 Non-Runners Runners Non-Runners Runners* 
Thymus 2.4 + 0.2a 1.3 + 0.1b 1.1 + 0.1b 0.9 + 0.1b
Spleen 2.5 + 0.1a 1.9 + 0.1b 1.8 + 0.1b,c 1.3 + 0.1c
Liver 29.6 + 0.8a 28.2 + 1.4a 25.5 + 0.5a,b 20.7 + 1.4b
Kidneys 7.7 + 0.2 8.2 + 0.2 7.8 + 0.1 8.7 + 0.4
Adrenal Glands 0.25 + 0.02 0.26 + 0.02 0.31 + 0.03 0.37 + 0.05
Retroperitoneal 
Fat 
0.51 + 0.43 0 + 0 0 + 0 0 + 0
Epididymal Fat 1.64 + 0.39 0.59 + 0.19 0.57 + 0.17 0.30 + 0.12
Perirenal Fat 0.45 + 0.13 0.35 + 0.13 0.38 + 0.10 0.09 + 0.06
Brown Fat 1.50 + 0.09a 1.33 + 0.09a 1.26 + 0.06a,b 0.90 + 0.10b
 
Note:  Values are expressed as mean g/kg + SEM; significant differences at p<0.05 




nearly 3x lower thymus weights than the sedentary AL-fed animals.  Exercising animals 
on the RF schedule and fed the RS-diet had nearly 1.5x lower thymus weights than those 
fed the C-diet, but this finding was non-significant. 
There was also a significant diet*feeding (p=0.003) and activity*feeding 
(p<0.001) interaction for spleen weights.  In the C-diet, animals on the RF schedule had 
1.5x lower spleen weights than those fed AL.  In the RS-diet, animals on the RF schedule 
had more than 2x lower spleen weights than those fed AL.  In animals fed AL, the spleen 
Table 6.  Tissues and Fat Pad Weights (Restricted Feeding) 
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weights for exercising animals was only slightly different from the sedentary animals 
(3.21g/kg vs. 3.16g/kg, respectively); however, in animals on the RF schedule, the spleen 
weights for exercising animals was nearly 1.4x lower than the sedentary animals.  There 
were no significant interactions for liver weights. 
Kidneys and Adrenal Glands.  Tables 5 and 6 provide data of the mean weights 
(+SEM) of the kidney and adrenal glands expressed as grams per kilogram of body 
weight. Feeding schedules had a significant main effect on both the kidneys and adrenal 
glands (p=0.02 and p<0.0001, respectively).  In animals on the RF schedule, kidney and 
adrenal gland weights were 1.04x and 1.6x higher, respectively, than those AL-fed.  
Exercising had a significant main effect on kidney weight (p=0.04) but not for adrenal 
gland weights (p=0.10).  Exercising animals had 1.04x higher kidney weights than those 
that were sedentary.  On the other hand, diet only had a significant main effect on adrenal 
gland weights (p=0.03) but not for kidney weights (p=0.91).  Animals on the RS-diet had 
1.2x higher adrenal weights than those fed the C-diet. 
There was a significant activity*feeding interaction for kidney weights (p=0.02).  
In animals on the RF schedule, those that exercised had 1.1x higher kidney weights than 
those that were sedentary.  However, in AL-fed animals, both exercising and sedentary 
animals had similar kidney weights with the exercising animals having slightly lower 
kidney weights than the sedentary animals (7.73g/kg and 7.78g/kg, respectively).  In 
addition, there was a significant diet*feeding interaction for adrenal gland weights 
(p=0.03).  In the C-diet, RF animals had only 1.4x higher adrenal weights than those AL-
fed.  In the RS-diet, RF animals had 1.8x higher adrenal weights than those fed AL. 
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Retroperitoneal Fat, Epididymal Fat, and Perirenal Fat.  Tables 5 and 6 
provide information of the mean weights (+SEM) of retroperitoneal, epididymal, and 
perirenal fat pad weights in grams per kilogram of body weight.  There was a significant 
main effect of diet, feeding schedule, and activity on retroperitoneal, epididymal, and 
perirenal fat pad weights.  Animals fed the RS-diet had approximately 2x, 1.4x, and 1.4x 
lower retroperitoneal, epididymal, and perirenal fat pad weights, respectively, when 
compared to those fed the C-diet (p=0.0179, p=0.0003, and p=0.0044, respectively).  
Animals on the RF schedule had over 7.5x, 6.5x, and 3x lower retroperitoneal, 
epididymal, and perirenal fat pad weights, respectively, than those AL-fed (p<0.0001).  
Exercising animals had 2.7x, 1.6x, and 1.5x lower retroperitoneal, epididymal, and 
perirenal fat pad weights, respectively, when compared to sedentary animals (p=0.0015, 
p<0.0001, and p=0.0008, respectively). 
Although there were no significant interactions for retroperitoneal and perirenal 
fat weights, there was a significant activity*feeding interaction for epididymal fat pad 
weights (p=0.0091).  In sedentary animals, RF decreased epididymal fat weights by 
nearly 6x the weight of those AL-fed.  In exercising animals, RF decreased epididymal 
fat weights by approximately 9x the fat weight of those AL-fed. 
Brown Fat.  Tables 5 and 6 provide data for mean brown fat pad weights (+SEM) 
in grams per kilogram of body weight.  Both diet and feeding had significant main effects 
on brown fat pad weights.  Animals fed the RS-diet had about 1.2x lower brown fat 
weights than those fed the C-diet (p=0.0003).  Likewise, animals on the RF schedule had 
approximately 1.2x lower brown fat weights than those AL-fed (p=0.0001).  In addition, 

















pad weights.  In AL-feeding, exercising increased the weights of brown fat only slightly 
when compared to the sedentary animals (1.55g/kg vs. 1.49g/kg, respectively); however, 
in RF, exercising animals had approximately 1.2x lower weights for brown fat compared 
to sedentary animals (Figure 11). 
Stress Hormones (Epinephrine, Norepinephrine, and Corticosterone) 
Tables 7 and 8 provide information for mean epinephrine, norepinephrine, and 
corticosterone levels (+SEM).  Overall, exercising and feeding schedule had a significant 
effect on epinephrine, norepinephrine, and corticosterone levels.  Exercising animals had  
Figure 11. Brown Fat (activity x feeding)  
Note: AL=ad libitum, RF=restricted feeding; significant differences (Tukey-Kramer 



























1.4x, 1.3x, and 1.9x more epinephrine, norepinephrine, and corticosterone levels, 
respectively, than sedentary animals (p<0.05, p=0.02, and p=0.02, respectively).  
Additionally, those on the RF schedule had 1.5x, 1.8x, and 2.4x higher epinephrine, 
norepinephrine, and corticosterone levels, respectively, than those fed AL (p=0.0003, 
p<0.0001, and p<0.0001, respectively).   
Diet did not have a significant main effect on epinephrine, norepinephrine, and 
corticosterone levels (p=0.25, p=0.27, and p=0.70, respectively); however, it did have a 
significant interaction with the feeding schedule (p=0.002) as well as with the feeding 
 
 Ad Libitum 
 Control Resistant Starch 
 Non-Runners Runners Non-Runners Runners 
Epinephrine 
(ng/mL) 
2.06 + 0.26 2.40 + 0.51 1.44 + 0.16 2.36 + 0.33
Norepinephrine 
(ng/mL) 
1.08 + 0.15 1.47 + 0.26 0.79 + 0.06 1.01 + 0.12
Corticosterone 
(ng/mL) 
791 + 161 1000 + 169 601 + 106 1207 + 154
Glucagon 
(pg/mL) 
56 + 8 49 + 8 116 + 12 92 + 10
Insulin (ng/mL) 0.77 + 0.08 0.96 + 0.41 0.53 + 0.04 0.52 + 0.04
Plasma glucose 
(mg/dL) 
183 + 14 170 + 7 179 + 16 177 + 14
 
Note: Values are expressed as mean + SEM; significant differences considered at 
p<0.05 (Tukey-Kramer Test); n=7  
 





schedule and activity (p=0.022) for norepinephrine levels only.  In the C-diet, animals on 
the RF schedule produced roughly 1.3x more norepinephrine levels than those fed AL 
while in the RS-diet, animals on the RF schedule produced approximately 2.6x the 
norepinephrine levels than the animals AL-fed.  Figure 12 demonstrates a significant 
diet*feeding*activity interaction.  In the C-diet, there were no significant differences in 
norepinephrine levels between exercising and sedentary animals on the RF schedule 
(p=0.99); however, in the RS-diet, exercising animals on the RF schedule had 1.7x higher 
norepinephrine levels than sedentary RF animals (p=0.04).  In addition, RS-diet, 
exercising RF animals had nearly 4x higher levels of norepinephrine than its respective  
 Restricted Feeding 
 Control Resistant Starch 
 Non-Runners Runners Non-Runners Runners 
Epinephrine 
(ng/mL) 
3.25 + 0.73 3.27 + 0.84 3.38 + 1.06 6.10 + 1.20^
Norepinephrine 
(ng/mL) 
1.75 + 0.26a 1.51 + 0.24a 1.17 + 0.26a 2.99 + 0.57b^
Corticosterone 
(ng/mL) 
1705 + 353 2373 + 701 1777 + 195 2647 + 403*
Glucagon 
(pg/mL) 
39 + 4a 73 + 28a,b 80 + 11a,b 173 + 86b*
Insulin (ng/mL) 0.40 + 0.01 0.39 + 0.01 0.38 + 0 0.37 + 0*
Plasma glucose 
(mg/dL) 
140 + 14 117 + 14 115 + 12 97 + 22^
 
Note: Values are expressed as mean + SEM; significant differences at p<0.05 are 
indicated by a, b (Tukey-Kramer Test); n=7 unless otherwise specified; *n=6; ^n=4 
 
















controls (p<0.0001).  ABA animals fed the RS-diet had nearly 2x the level of 
norepinephrine than the ABA animals fed the C-diet (p=0.007). 
Diet Hormones and Glucose 
Glucagon.  Tables 7 and 8 also show data for mean glucagon levels (+SEM).  
Diet had a significant main effect on plasma glucagon levels with animals on the RS-diet 
having 1.7x higher levels than those fed the C-diet (p=0.001).  Activity and feeding 
schedule did not have a significant main effect on glucagon levels among the treatment 
groups (p=0.25 and p=0.60, respectively); however, there was a significant 
activity*feeding interaction for glucagon levels (p=0.02).  In AL-fed animals, plasma 
Figure 12. Norepinephrine (diet x feeding x activity)  
Note: AL=ad libitum, RF=restricted feeding, C=control diet, RS=resistant starch 



















glucagon levels were approximately 1.2x lower for the exercising animals when 
compared to the sedentary animals.  In RF animals, plasma glucagon levels for exercising 
animals were more than 2x higher than that of the sedentary animals.   
Insulin and Plasma Glucose.  Tables 7 and 8 show data for mean insulin and 
plasma glucose levels (+SEM).  There was a significant main effect of feeding on insulin 
and plasma glucose levels.  Animals on the RF schedule had 1.8x and 1.5x lower levels 
of insulin and plasma glucose levels, respectively, when compared to AL-fed animals 
(p=0.006 and p<0.001, respectively).  Diet and activity did not have any significant main 






The present study was designed to determine whether resistant starch could 
ameliorate the outcomes of the activity-based anorexia (ABA) model.  The results of the 
experiment also served to validate this specific procedure as an ABA paradigm.  
Consistent with many previous studies, young, male rats from our study exhibited 
decreased food intake, reduced body weight, and elevated wheel running when exposed 
to ABA conditions (Beneke et al., 1995; V. R. Burden et al., 1993; Doerries et al., 1991; 
Dwyer & Boakes, 1997; Epling & Pierce, 1984; Lett et al., 2001; Routtenberg & 
Kuznesof, 1967; Tokuyama et al., 1982).  Additionally, similar to many other studies, the 
ABA paradigm increased the weights of the adrenal glands and decreased the weights of 
the thymus glands (V. R. Burden et al., 1993; Hara et al., 1981; Ness et al., 1995) and 
spleens (Hara et al., 1981).  Moreover, ABA demonstrated reduced body fat when 
compared to other treatment groups (V. R. Burden et al., 1993).  Comparable to other 
studies, the resistant starch (RS) diet independently decreased retroperitoneal, 
epididymal, perirenal, and brown adipose tissue (de Deckere, Kloots, & van Amelsvoort, 
1995; Francis et al., 2003; Hegsted et al., 2003; Kishida et al., 2001; Pawlak et al., 2001).  
Lastly, as expected, ABA animals demonstrated elevated levels of catabolic hormones 
compared to controls (V. R. Burden et al., 1993; Licinio et al., 1996). 
Although the ABA outcomes were consistent with many earlier studies, the study 
did not support our hypothesis that resistant starch (RS) will attenuate the anorexic 
effects of the ABA model; rather RS exacerbated the conditions of anorexia in these rats.  
The effects described above were reported at a greater extent in animals fed the RS-diet 
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than the animals fed the control (C) diet.  For example, the ABA animals of the RS-diet 
group lost an average of 22% and 28% of their pre-experimental body weight, whilst the 
ABA animals of the C-diet lost an average of 15% and 20% of their initial weight by 
days 3 and 4, respectively (pre-experimental data not shown).  By the end of the 
experiment (day 5 or 6), the ABA animals fed the RS-diet significantly lost twice as 
much weight than did the ABA animals fed the C-diet.   
In addition, on day 3-4, cumulative data shows that RS-fed ABA animals ran 
roughly 24% more and ate approximately 19% less g/kg (or 30% less kcal/kg) when 
compared to ABA animals given the C-diet.  Furthermore, sedentary animals on the 
restricted feeding (RF) schedule in the RS-diet group lost 16% more weight by the end of 
the study while consuming only 3% less kcal/kg on day 3-4 than did the ABA animals 
fed the C-diet.  A past study by Roy and lab demonstrated that rats fed a low-energy 
density diet increased food intake to increase energy consumption (H. J. Roy et al., 
2003).  In this study, ABA animals fed the RS-diet consumed significantly less kcal/kg 
than did the ABA animals fed the C-diet.  Also, the RS-diet, in combination with the 
ABA paradigm, initiated a significant reduction in brown fat as well as an elevation of 
norepinephrine levels.  These findings strongly show that the resistant starch diet resulted 
in an accelerated progression to anorexia when used in conjunction with the ABA 
paradigm.   
To our knowledge, studies regarding ABA with respect to diet composition are 
limited; thus, we attempted to manipulate the diet to examine the possible outcomes.  
Although RS has been shown to decrease fat pad weights (de Deckere et al., 1995; 
Francis et al., 2003; Hegsted et al., 2003; Kishida et al., 2001; Pawlak et al., 2001), it has 
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also been shown to display a gradual rise and steady leveling of post-prandial blood 
glucose responses rather than producing the transient hyperglycemia and transient 
hypoglycemia periods as would a high glycemic starch diet (Behall & Hallfrisch, 2002; 
Hallfrisch & Behall, 2000; Raben, Tagliabue et al., 1994).  This demonstration of glucose 
control may influence the rate of hormone production and secretion, particularly the 
catabolic hormones (J. E. Hall & Adair, 1998), thereby suggesting that incorporation of 
resistant starch into the diet can regulate the breakdown and mobilization of energy 
stores.  
In a past study, rats were fed at the onset of the dark cycle and killed at the onset 
of the dark cycle.  The researchers reported significant differences in glucose and insulin 
responses between ad libitum (AL) and RF treatments (V. R. Burden et al., 1993).  
Conversely, in our study, the meal period preceded the onset of the dark cycle and the 
animals were killed at that time as well.  There were no significant differences between 
levels of insulin in ABA animals compared to their respective controls; however, the 
levels of plasma glucose levels were significantly reduced in ABA animals compared to 
their controls.  It was expected that the glucose levels of the ABA animals on the RS-diet 
would be higher than those on the C-diet due to the ability of RS to maintain a steady 
glucose level.  However, because the ABA animals from both diet groups were fasted for 
at least 22.5 hours, it is suggested that the glucose levels of the ABA animals on the RS-
diet declined to the levels similar to those on the C-diet.  Perhaps, if the samples were 
taken some hours earlier, there would have been a significant difference between the two 
ABA groups. 
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It has been well established that in order to raise blood glucose levels and produce 
energy for bodily needs, catabolic hormones such as glucagon, norepinephrine, 
epinephrine, and corticosterone work similarly to promote glycogenolysis and 
gluconeogenesis, increase lipolysis and ketogenesis, and decrease cellular uptake of 
glucose (Groff & Gropper, 2000; J. E. Hall & Adair, 1998).  We proposed that if the 
blood glucose levels were maintained at euglycemic levels, the production and release of 
these catabolic hormones would not be necessary at an elevated rate and the body’s 
energy storage will not be utilized to a great extent.   
In our study, the levels of norepinephrine, epinephrine, and corticosterone 
significantly increased in ABA rats fed the RS-diet when compared to their respective 
controls.  Moreover, only the norepinephrine leve ls of ABA animals fed the RS-diet were 
significantly higher than the ABA animals fed the C-diet.  On the other hand, only 
corticosterone levels significantly elevated in ABA rats fed the C-diet compared to their 
respective controls.  Similarly, Burden and co-authors showed an increase in 
corticosterone levels in experimental animals; however, they found norepinephrine levels 
to be consistent among all groups (V. R. Burden et al., 1993).    Because the ABA 
animals were exercising and restricted of food for a long period of time, immediate 
glucose availability was insufficient to meet the demands of the body; therefore, these 
animals exhibit high secretions of corticosterone.  In contrast to our expectations, the 
glucose levels of ABA animals fed the RS-diet were not maintained at a steady, 
euglycemic level by the time the meal is usually provided; thus, there were high 
elevations of all three catabolic hormones (i.e., corticosterone, norepinephrine, and 
epinephrine). 
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Because glucagon is a hormone that helps to maintain body homeostasis during 
times of fasting, plasma glucagon levels were suggested to be elevated in the RF animals 
(J. E. Hall & Adair, 1998).  Contrastingly, in our study, there were no significant 
differences between ABA groups and their respective controls.  On the other hand, Gee 
and associates found that there was no significant effect of RS on plasma glucagon levels 
between experimental and control groups (Gee, Faulks, & Johnson, 1991; Gee & 
Johnson, 1990).  Similarly, there were no significant differences between our control 
groups (i.e., sedentary AL-fed animals) or any other corresponding pairs (i.e., sedentary 
AL-fed animals, exercising AL-fed animals, sedentary RF animals, or ABA animals) 
from each diet treatment.  This finding suggests that glucagon may not play a role in 
ABA. 
In the fasting state, low levels of circulating insulin and increased levels of 
norepinephrine and epinephrine promote lipolysis (Groff & Gropper, 2000).  
Additionally, catecholamines have been suggested to be associated with corticosterone 
(Gillies & Grossman, 1985; Licinio et al., 1996); particularly, corticosterone is proposed 
to exert permissive effects on epinephrine and norepinephrine (J. E. Hall & Adair, 1998).  
Therefore, we suggest that if all three of these levels are elevated, lipolysis will be further 
stimulated (Devenport, Knehans, Sundstrom, & Thomas, 1989; Guyton, 1987).  
Evidently, the ABA animals fed RS-diet demonstrated significant elevations of these 
catabolic hormones, which were at higher levels than the ABA animals of the C-diet, 
thus, contributing to the greater loss of body weight and body fat.  However, ABA 
animals of the C-diet did not display elevated levels of norepinephrine and epinephrine 
levels as they did corticosterone levels.  Therefore, it is suggested that the body weight 
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and fat reduction occurred at a lesser extent in the ABA animals fed the C-diet compared 
to the ABA animals fed the RS-diet because only corticosterone levels were elevated.  
Literature indicates that epinephrine is more potent than norepinephrine, which functions 
primarily as a neurotransmitter (Groff & Gropper, 2000); therefore, it cannot be 
explained why norepinephrine levels in ABA animals fed the RS-diet were higher than 
those fed the C-diet, while corticosterone and epinephrine levels were not significantly 
different between the two ABA groups. 
 Exercise tends to increase norepinephrine concentrations; thus it is believed that 
exercise- induced food intake suppression has been associated with increased plasma 
norepinephrine concentrations (Duncan et al., 1985; Guilland, Moreau, Genet, & 
Klepping, 1988; Kohno et al., 2000).  Our study supported the idea that elevated exercise 
and suppressed food intake both contribute to high norepinephrine levels.  The 
norepinephrine levels in ABA rats fed the RS-diet were significantly higher than their 
respective controls; however, this did not occur in the C-diet.  Furthermore, the ABA of 
the RS-diet had significantly higher levels of norepinephrine compared to the animals fed 
the C-diet.  Accompanying these elevated levels of norepinephrine were high levels of 
activity and lower amounts of caloric intake when compared to ABA animals fed the C-
diet.   
Because the adrenal glands control the secretion of corticosterone, it has been 
suggested that if corticosterone release is not regulated, high levels of this hormone can 
significantly impair the immune system, thus, leading to atrophy of the thymus glands (J. 
E. Hall & Adair, 1998).  In our study, ABA animals exhibited lower, atrophic thymus 
weights as well as significantly higher levels of corticosterone compared to their 
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corresponding controls.  In addition, ABA animals of the RS-diet demonstrated 
hypertrophic adrenal glands, which further supports the idea that elevated levels of 
corticosterone from the adrenal glands may hinder immune functions. 
Summary and Conclusion 
The purpose of this study was to determine whether resistant starch (RS) can 
ameliorate the anorexia associated with the activity-based anorexia (ABA) paradigm.  It 
was believed that a high GI diet produces transient post-prandial hyper- and hypo-
glycemia.  Conversely, because animals fed RS slowly digest and absorb glucose, they 
are able to maintain euglycemia for a longer period of time when compared to those fed a 
high GI diet.  Therefore, if euglycemia is sustained, there will be less, if any, stimulation 
of catabolic hormone release and energy stores will not be catabolized.  Higher body 
stores are suggested to attenuate wheel running associated with ABA (Fish & Lewis, 
1996).  Therefore, if the animals are fed a diet containing RS while exposed to the 
standard ABA procedure, the effects of the ABA model will be ameliorated.  
  Our study showed that this specific procedure developed the typical ABA 
outcomes in rats.  Additionally, the results suggest that the anorexic responses only 
occurred when restricted-feeding and exercising were administered together.  
Furthermore, when given RS in the diet, these anorexic responses develop at an even 
faster rate.  Therefore, our diet manipulation suggests a non-beneficial outcome for 
anorexia.  However, these results also indicate a method to accelerate the outcomes of 
ABA. 
By the end of the study (day 5 and 6), ABA rats fed the RS-diet had 
approximately 30% weight loss compared to the 20% weight loss illustrated by the ABA 
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rats fed the C-diet.  RS-fed ABA rats ran approximately 24% more and ate 30% less 
kcal/kg compared to the ABA rats fed the C-diet.  This finding may explain the reason 
for the non-significant differences in the adrenal gland weights, brown fat weights, 
epinephrine levels, and norepinephrine levels between ABA and control rats fed the C-
diet.  In addition, it was expected that the glucose levels of RS-fed rats be at euglycemic 
levels; however, meal restriction (22hrs) was probably too severe for the RS-fed ABA 
rats to maintain the levels that were expected of the low GI characteristic of RS.  The 
faster progression to anorexia and cachexia demonstrated by ABA rats fed the RS-diet 
can be contributed to low glucose levels, which stimulated corticosterone.  Also, food 
intake suppression and high activity levels played a role in elevating levels of epinephrine 
and norepinephrine.  Collectively, elevated levels corticosterone, epinephrine, and 
norepinephrine, which have all been implicated in catabolism, contributed to the 
outcomes seen RS-fed ABA rats. 
Therefore, when animals are restricted-fed and allowed access to the activity 
wheels, the combination of these two stress- factors initiates the anorexic and cachexic 
responses.  This study provided valuable information on the relationship among diet, 
activity, and food consumption. In our study, RS accelerated the outcomes of ABA; 
therefore, it served as a means to increase the severity of ABA rather than the opposite.  
Although RS is not recommended in treatment of activity anorexia, it can be considered 
in the treatment of obesity or as a weight loss program. 
Future Directions  
It is important to determine what characteristics are associated with anorexia.  
More specifically, it would be valuable to determine which factors stimulate, accelerate, 
 80 
delay, or inhibit the progression to anorexia.  Anorexia nervosa is affecting more 
individuals at a younger age, particularly females between 9-14 years of age, although 
this is not to exclude those at older ages.  Abnormally intense exercising and severe 
dieting have a dramatic effect on this eating disorder.  Therefore, further studies should 
be conducted to determine what type of diet can provide more efficient immediate energy 
and stored energy in order to delay the cachexia found in individuals diagnosed with 
anorexia nervosa.  Perhaps a high-energy density diet that provides slow-absorbing 
glucose can prove to be beneficial.  In addition, studies should focus on causes for the 
initiation of the onset of exercise and sustaining of high levels of activity.  Lastly, studies 
should determine what factors can overcome the exercise-induced food intake 
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SECTION 1: Principal Investigator 
Name:         Maren Hegsted 
 
 
                    Roy Martin  
   Office Phone: 578-1518 
Home Phone: 769-3097 
 
Office Phone: 578-2284 
E-mail address: 
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SECTION 2: Project Title (Enter the name of your project/course number in the block 
below) 
 






SECTION 3:  
Animal Species  
 





           Zucker 
           Spague-Dawley 
Number of animals 
needed: 
 
Year 1:        130            
 
Year 2:        170            
 




at one time:    80                
 
Year 1 and 2 
Wistar – up to 80 
Zucker – up to 120 
Sprague-Dawley – up 
to100 
 
Number of animals to be placed in 
each group:   _6 to 10      
Year 1 
Training: up to 10 rats 
Study 1:  10 rats x 4 groups = 40 rats 
Study 2:  10 rats x 8 groups = 80 rats 
Year 2 
Training: up to 10 rats  
Study 3: 10 rats x 8 groups = 80 rats 
Study 4: 10 rats x 8 groups = 80 rats 
 
PROTOCOL NUMBER:         01-086            
     
APPROVAL DATE:                             
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Animal housing and veterinary care have been coordinated with DLAM office OR LSU 
Agricultural Center Unit.  
 
X    YES 
       NO 
Name of Animal Housing Representative Contacted (typed):   Laurie Henderson                   
 
Signature (required):                                                                 
 
         
 
Location of Animals 
 
 DLAM Vivarium X Life Sciences Vivarium 
 SVM Barns  SVM Fish Building 
 LAES (List Site):  Other (List Site): 
 
 Field Study (Do not complete sections 6, 11, and 12 
 
SECTION 4: Abstract Plan of Research/Teaching 
Provide a brief layman’s description of the project in the block below. 
 
 
There is a possible link between weight gain, fat accumulation, and bone density in a diet 
comprising or low versus high glycemic index (GI) foods. We will be testing methodology to 
determine optimum procedures and rat strains to be used in future research projects. The rats will 
be fed a high GI diet or a low GI diet for 12 weeks. The modifications in GI will be achieved by 
using a waxy cornstarch (100% amylopectin) for the high GI diet and Hi-maize (40% amylopectin 
and 60% amylose) for the low GI diet. . Amylopectin is rapidly digested in the stomach and small 
intestine quickly releasing glucose into the blood stream. Amylose is resistant to amylase 
hydrolysis and is fermented in the cecum and colon producing short chain fatty acids, primarily 
acetate, butyrate and propionate. Diets will be based on a modified AIN93-G diet with 35% of 
calories from fat, 45% from carbohydrate and 20% from protein. 
 
The initial study will consist of 4 diet treatment groups consisting of the two diets (high GI or low 
GI) and two feeding methods (meal fed or ad libitum). Meal fed animals will be fed twice daily 
with food available for 30 minutes in the morning and one hour in the evening. There will be a 
12/12-hour light/ dark cycle set so the evening meal will be offered at the beginning of the dark 
cycle. The ad libitum fed rats will have diet available to them 24-hours per day.  
 
Abdominal fat and bone density will be estimated in the beginning and at three-week intervals in 
the anesthetized animals using a SABRE peripheral dual energy x-ray absorptiometer (pDEXA). 
Non-fasting blood will be drawn through retro orbital sinus bleeding during the first and last 
pDexa for leptin analysis. After 12 weeks, rats will be fasted overnight, anesthetized with 
isoflurane, and blood drawn by cardiac puncture prior to dissection. Abdominal fat depots and 
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liver will be removed, weighed, and frozen in liquid nitrogen. The rat carcass will be eviscerated 
and frozen for later proximate analysis. Cecal and colon weight and length will be measured to 
determine the effects of amylose on colon growth.   
 
The results from this initial study will determine the optimum feeding method (meal fed vs ad 
libitum) to be used in used in the subsequent studies.  
 
STUDY 2, 3, 4: 
Once the optimum feeding method (meal feed vs ad libitum) has been determined, future studies 
will determine variances between strain (Wistar, Obese Zucker, Lean Zucker, Sprague-Dawley) 
and sex (male vs female) using the same diet treatment groups (high GI and low GI). Each study 
will be comprised of 6 to 10 animals per grouping.  All procedures will be duplicated in the same 




SECTION 5: Investigator’s Statement.  Assurances for the Humane Care and Use of 
Vertebrate Animals. 
  
By signing this form, we agree to abide by the Policy for the Care and Use of Animals of Louisiana 
State University, or that of the LSU Agricultural Center.  This project will be in accordance with the 
NIH “Guide for the Care and Use of Laboratory Animals” (except as explained in the accompanying 
protocol), and the Louisiana State University or the LSU Agricultural Center Animal Welfare 
Assurance on file with the U.S. Public Health Service.   
I further assure the Committee that: 1) I will abide by all federal, state, and local laws and 
regulations governing the use of animals in teaching and research; 2) the investigators and 
technicians are adequately trained to perform the research techniques required in these 
studies; and 3) the fewest number of animals required to produce significant results are being 
used in this study. 
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Investigator Signature    Title/Rank   Date 
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(Type Name of Co-Investigator) 
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Investigator Signature    Title/Rank   Date 
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(Type Name of Co-Investigator) 
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SECTION 6: Special Husbandry Requirements 
 





  (F) 70-72 Humidity:                                      (%)




Stainless Steel wire cages 
Size:  
SINGLE 
Filter tops required? YES 
(During transport for pDexa) 
BEDDING/LITTE
R 
Type: corncob Autoclaved? No Changes/week: 
We will do 
WATER Sterile: De-ionized: Acidified: Tap: 
YES 
Other: 
DIET Special Feeding Requirements: We will feed  
OTHER SPECIAL 
NEEDS 
Red incandescent light if available 
 
2. NO (If you indicate ‘No’, your animals will be cared for according to standard operating 
procedures of DLAM) 
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3. Not Applicable 
 
SECTION 7: Hazardous Materials 





     YES        X  NO 
 
Agent(s):                            
      EXEMPT 
 
IBRDS Chairman Signature: 
                                                
Radioisotopes? 
 
    YES          X   NO 
 
Isotope(s):                                




     YES            NO 
Hazardous Chemicals? 
 
    YES         X    NO 
 
Compound(s):                          
 
Note: If zoonotic (infectious to humans) or recombinant organisms are to be used, this protocol 
request must be submitted to the Biohazardous Materials Safety Committee for approval 
PRIOR TO CONSIDERATION by the IACUC. Similarly, if hazardous chemicals are to be 
used in the animal room, submit the proposal to the Chemical Safety Committee for prior 
approval. P.I. MUST PROVIDE health and safety measures for animal technicians and 
facility maintenance personnel. In Standard Operating Procedure (SOP) form, describe any 
precautions, procedures, or personal protection required in handling animals or waste 
containing listed agents or compounds, or in working in or around the animal room 




SECTION 8: Summary of Procedures 
Your response in this section should provide the reader with a complete description of how every 
animal to be used in this project is to be treated during every phase of the study. Your target audience 
is a faculty member from a discipline unrelated to yours. Do not use jargon.  Please include the 
following information: 
          
4. The rationale for using animals.  Why should this study be done?  What hypothesis will 
be tested? 
5. How and/or why you selected the animal species indicated. 
6. How you arrived at the number of animals to be used. 
7. A complete description of the proposed use of the animals.  Describe the experimental 
design of the study.  Include a list of any physical, chemical or biological agents (name, 
dose, volume, route, frequency) that may be administered.  Tables and outlines are 
helpful to indicate group assignments and study progression. 
8. A description of procedures designed to assure that discomfort and injury to animals 
would be limited to that which is unavoidable in the conduct of scientifically valuable 
research.  Indicate how analgesic, anesthetic, and tranquilizing agents will be used where 
appropriate, to minimize discomfort and pain to the animals.  It is advisable that you 
obtain input from LSU’s Attending Veterinarian (Dr. David Baker) or from another 
veterinarian familiar with the species to be used. 
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9. A description of any euthanasia method to be used.  
Wistar, Zucker, and Sprague-Dawley Rats will be used as Animal models for evaluating the effects 
of variable diets of high or low Glycemic Index starches with constant calorie and protein content. 
Male Wistar Rats will be used in the initial study to determine if there is a significant difference in 
weight gain, fat accumulation, and bone density between the two starches and between the two 
feeding methods. Male Wistar Rats between the ages of 7 to 20 weeks show a higher growth curve 
than most strains, so there is a higher probability of weight gain during the 12-week study. This will 
allow us to analyze data and make decisions on how to proceed with future studies. Once the 
methodology is determined, future studies will compare strain and sex. Male and female Wistar, 
Obese Zucker, Lean Zucker, and Sprague-Dawley rats will be used to determine if those results can 
be duplicated.  By using the selected rat strains as animal models, we are better able to replicate the 
variation in human populations.  Each study will use the same methodology (diet, light cycle, caging, 
and procedures), with the exception of the feeding method (ad libitum vs. meal fed), since the 
optimum feeding method will be determined during the initial study.  
 
Rats will be blocked by weight, and randomly assigned to diet treatment groups. Each group will 
consist of a minimum of 6 to a maximum of 10 rats per group. The initial study will use 10 animals 
per treatment group (4 groups, N=40). Wistar rats are economical, therefore 10 rats per group will 
allow for possible loss of animals during anesthesia and retro orbital sinus bleeding. Once we have 
perfected these procedures, fewer numbers may be needed per treatment group in future studies. The 
final number of rats used for these studies will be determined after analysis of data from the initial 
study.  An additional ten rats will be ordered from one of the DLAM facilities for training. A DLAM 
veterinarian will teach staff and students proper methods for anesthesia, retro-orbital bleeding, heart 
puncture and dissection.  
 
The animals will be single housed in wire stainless steel cages. We will measure food intake, and 
weigh backs will be used to measure spillage. We will feed all animals and change caging. Clean 
water bottles and fresh water will need to be provided at all times by the Lab animal staff.  
 
The rats will be fed a high GI diet or a low GI diet for 12 weeks. The modifications in GI will be 
achieved by using a waxy cornstarch (100% amylopectin) for the high GI diet and Hi-maize (40% 
amylopectin and 60% amylose) for the low GI diet. . Amylopectin is rapidly digested in the stomach 
and small intestine quickly releasing glucose into the blood stream. Amylose is resistant to amylase 
hydrolysis and is fermented in the cecum and colon producing short chain fatty acids, primarily 
acetate, butyrate and propionate. Amylopectin provides 4 kcal/g as glucose while amylose provides 
about 2 kcal/g as fatty acids in fermentation. Diets will be based on a modified AIN93-G diet with 
35% of calories from fat, 45% from carbohydrate and 20% from protein. 
 
STUDY 1:  
4 diet treatment groups with 10 Male Wistar rats randomly assigned to each group: 
1) High GI, meal fed 
2) Low GI, meal fed 
3) High GI, ad libitum fed 
4) Low GI, ad libitum fed 
The meal fed animals will be fed twice daily with food available from 0830 to 0900 in the morning 
and from 1600-1700 in the afternoon. The light dark cycle will be light from 0400-1600 and dark 
from 1600-0400 so the one-hour evening meal will be offered at the beginning of the dark cycle. The 
ad libitum fed rats will have diet available to them 24-hours per day with food intake, including 
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spillage, recorded three times weekly. All Rats will be weighed three times per week. Future studies 
will use 2 diet treatment groups using the Low GI and High GI diets stated above, and one feeding 
method. 
 
Isoflurane will be used for anesthesia. Artificial tear ointment will be used in both eyes of each rat 
while anesthetized to prevent eye damage. Abdominal fat and bone density will be estimated at the 
beginning and at three-week intervals in the anesthetized animals using a SABRE peripheral dual 
energy x-ray absorptiometer (pDEXA). During the first and last pDEXA, while still under anesthesia, 
400ul of blood will be drawn through retro orbital sinus bleeding for leptin analysis. The pDexa 
machine is located in the nutrition lab, room 548 of the Life Science building, next to the service 
elevator directly under the 6th floor Life Science Vivarium.  For each of the five scheduled 
procedures, the rats will be brought, four to six at a time, in shoe boxes with micro isolator lids from 
their animal room in the Vivarium to the Nutrition lab on the 5th floor. They will be returned 
immediately after recovery to their original cage. Additional monitoring will take place after the retro 
orbital bleeding is performed. An antibiotic opthalmic ointment will be used to treat any animals with 
visible eye irritation.   
 
After 12 weeks, rats will be fasted overnight and moved individually to the necropsy room in the Life 
Science Vivarium. They will be anesthetized with isoflurane and up to 10cc of blood drawn by 
cardiac puncture with a syringe resulting in termination. Cervical dislocation will assure death prior 
to dissection. Abdominal fat depots and liver will be removed, weighed, and frozen in liquid 
nitrogen. The rat carcass will be eviscerated and frozen for later proximate analysis. Cecal and colon 
weight and length will be measured to determine the effects of amylose on colon growth.  
 
 
SECTION 9: Type of Project 
 TYPE A - Pain or distress will not be induced; animals will only be used for injections, 
collections, or procedures causing nothing more than minor discomfort; or will be 
humanely euthanized prior to induction of pain or distress. 
X TYPE B - Pain or distress will be relieved by appropriate therapy. 
 TYPE C - Drug intervention for pain or distress would interfere with the protocol.  (If 
this block is checked, specific justification MUST be provided.) 
 
 
SECTION 10: Check “Yes” or “No” to each of the following questions.  On a separate 
page, provide an explanation for any “Yes” answers that are not 
included in the above summary.   
Provide justification for why the action is needed, and include information in Section 8 above, such 
as who will perform procedures, how they will be performed, frequency, duration, drugs to be used, 
dosages, routes of administration, etc.  Not all of this information may be needed for every “Yes” 
answer.  The information you provide in this section is very important in highlighting specific points 
of your study that are important considerations for the IACUC in their review process.  
 
 





Will animals be restrained?  (Restraint refers to 
immobilization or other restrictions to normal 




X   
Will animals be fasted? 
 
 






Are any ANESTHETICS, ANALGESICS, or 











Are neuromuscular blocking agents to be used? 
Who will administer 
agents?...................................... 
How will animals be monitored?                                








Will surgical procedures be employed?  Are they: 
Survival               Multiple               Terminal            
Who will perform 
surgery?.......................................        
If survival: 
1) Who will be responsible for recovery of the        
animals?...................................................................
.. 
2) Who will maintain post-operative 
records?........... 
3) Where will records be maintained?               
4) Who will provide post-op 
analgesics?.................. 
Note: Survival surgeries must be conducted 
aseptically, and major surgical procedures 
performed on non-rodent species must be 














Do you anticipate any adverse effects of the 
experimental procedures on the animals (e.g., pain, 





Is death an endpoint in your experimental 
procedure?  Note: Death as an endpoint refers to 
acute toxicity testing, assessment of virulence of 
pathogens, neutralization tests for toxins, and 
other studies in which animals are not euthanized, 




 X Are there emergency treatments by the DLAM 






Are you using wild or exotic species for which 
permits are necessary?  (ATTACH COPY) 








Will animals be euthanized during or at the close 
of the study?   





 X Will animals be used for antibody production? N/A 
  
X 
Will Complete Freund’s Adjuvant be used?  If 
yes, please justify based on scientific reasons.      
 
N/A 







 Will blood be collected? 
How often?         3 TIMES                            
Volume?      400ul   two times (retro orbital)             
   10ml at euthanasia (cardiac puncture)                    
Who will collect 
blood?............................................ 
Note: Blood equal to 1.5% of the animal’s body 
weight per 2 weeks represents the upper approvable 








SECTION 11: Animal Management 
Individual (or groups of) animals are identified by (i.e. tag, tattoo):      cage cards                 
Check all applicable below: 
CARE OF SICK 
ANIMALS 
DISPOSAL OF DEAD 
ANIMALS 
PEST CONTROL 
   
X    Call Investigator 
    X    Clinician to Treat 
         Euthanasia 
  
 X    Call Investigator 
        Necropsy 
        Disposal.   
 
List any special requirements for 
disposal?                                      
 
      
        Call Investigator 
 X     Pesticides OK 
         No Pesticides 
 
         
 
SECTION 12: Disposition of Animals 
 





Animals will be euthanized. 
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DLAM/LAES has permission to REASSIGN animals to another IACUC-approved 
protocol. 
  
TRANSFER animals to the following IACUC-approved protocol(s). 
 
Please list Protocol Number:                                                          
 
  





SECTION 13: Narrative Statement 
Federal regulations mandate that you provide written, narrative statements for all projects: 
 
11. that the activities do not unnecessarily duplicate previous experiments.  In this statement, include 
sources used to make such a determination (e.g., Databases, workshops, expertise in the field, 
etc.)  If an electronic database was used, include database, years and words searched, and date of 
search. 
 
Note: Address the following items only if you indicated project Type B or C in SECTION 9. 
 
12. that you have considered alternatives to procedures producing more than momentary or slight 
pain or distress.  Indicate what those alternatives were and why they are not appropriate. 
 
13. describing the methods you used to determine that alternatives to such procedures were not 




The effects of high and low GI diets on weight gain; fat accumulation and bone density can 
only be analyzed using live animals. Previous studies using glycemic index starch diets did not 
allow for maximum weight gain, and did not analyze fat accumulation or variations in bone 
density. The Web of Science search system was used with the key words: glycemic index, 
insulin sensitivity, rats, resistant starch, amylose, amylopectin, glucose, weight gain, adipose 
tissue, and leptin for the years 1984 to present. Search was completed 10/25/2001 
 
 The only source of pain for this study will be as a result of the retro orbital bleeding. The 
animals will be under general anesthesia during the procedure and should have only mild and 
short-term discomfort after recovery. They will be monitored after the procedure for eye 
irritation and treated promptly as needed. This method was chosen as the optimum method of 
blood collection since there is less chance of self-mutilation at the collection site as in other 
recommended methods, including tail and saphaneous vein bleeding. Web of Science search 
system was used with the key words: retro orbital bleeding, rats, and blood collection for the 





SECTION 14: Investigator Training 
In accordance with IACUC policy, all personnel conducting animal-based research must attend a 
Rules and Regulations Course and verify their training, experience and skills in the care and use of 
the animals and techniques they are responsible for. 
 
List all persons involved in animal care and use for this study below. 
RULES AND REGULATIONS TRAINING COURSES 
Name Rules/Regulations  
Training Course 








Maren Hegsted             X     
YES 
                     NO
3/8/00      YES 
      NO 
        X     
YES 
                
NO 
Carol O’Neil             X     
YES 
                     NO
6/1/99      YES 
       NO 
         X    
YES 
            
NO 
Mike Keenan             X     
YES 
                     NO
3/9/99      YES 
       NO 
         X    
YES 
            
NO 
Kathleen L McCutcheon             X     
YES 
                     NO
11/6/01      YES 
       NO 
     X    
YES 
            
NO 
Anne R Francis             X     
YES 
                     NO
11/6/01      YES 
       NO 
      X   
YES 
           NO 
Rania Mekary             X     
YES 
                     NO
11/6/01      YES 
       NO 
          YES 
      X   
NO 
 
*  Exemption based on previous experience with the study species may be obtained by written 
request to the IACUC. 
 
** Training/Experience in assigned procedures for this protocol. 
 
 
Who will train individuals for participation in protocol procedures? 
            Dr. Maren Hegsted      
            Dr. Rhett Stout             
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Personnel participating in the project that have not attended the Rules and Regulations Course or the 
applicable Species Wet Lab, will have six (6) months from the approval date of the project to 
complete them.   
 
Rules and Regulations Courses will be held the first Tuesday of every month from 11:00 a.m. until 
Noon, in room 1212C, School of Veterinary Medicine.  The Wet Labs will be held on the same day 
beginning at 1:00 p.m. in the DLAM facility.  Please call Ms. Dawn Best-Desjardins at 578-9643 to 
sign up for these courses. 
 
SECTION 15: Occupational Health and Safety 
It is the responsibility of the principal investigator to conduct a hazard analysis and risk assessment 
to determine if personnel involved directly or indirectly in the study should participate in the 
Occupational Health Program administered through DLAM and the Student Health Center. 
 
Will project personnel participate in the Occupational Health Program? 
13. YES   
14. NO 
 
If yes, please name participants below, and have them contact Mr. Rick Ramsey at 578-9644 for 
information. 
 
                                                              
                                                               
 

















































APPENDIX C:   
 
IACUC  (PBRC) 
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PENNINGTON BIOMEDICAL RESEARCH CENTER 
INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE 
 
 Dr. David Baker, LSU SVM  Dr. Hans Berthoud, PBRC - Chair Dr. Randy Mynatt, 
PBRC 
 Dr. Lauri Byerley, PBRC Mrs. Diane Olinde, Community RepresentativeDr. Matrin Rossmeisl, PBRC 





GUIDELINES FOR SUBMISSION OF NEW PROTOCOL FORMS AND EXISTING 







A new protocol form must be filled out and submitted to the IACUC for approval: 
 
 1)  to receive formal approval to begin experiments/procedures outlined in a new protocol; 
 2)  if there are changes in major operative procedures in an existing protocol (the protocol is not assigned 
a new number); or 




All existing protocols are evaluated by the IACUC every three years.  The term renewal refers to IACUC 
action on a previously approved, but EXPIRING protocol.  A new *protocol form must be submitted for a 
renewal (for a maximum of up to three years).  If renewed by the IACUC, the protocol is not assigned a new 




A protocol may be amended if the original intent of the protocol does not change.  Protocol amendments 
include: 
 
1)  requests to extend the time remaining on protocols (not to exceed a total of 3 years); 
2)  changes in dosage; 
3)  changes in animal numbers; 
4)  changes in group designations; or 
5)  changes in time length of experiments. 
 
A new protocol form is not necessary; instead, simply submit a letter to the IACUC, citing the protocol 







INSTRUCTIONS FOR USING ANIMAL CARE AND USE PROTOCOL FORM: 
 
1. Changes or revisions may frequently be made by the Institutional Animal Care and 
Use Committee (IACUC) and this file location will always contain the latest revised 
version of the form. 
 
2. Retrieve the form.  Save the file in another location:  In the toolbar, select [File] and 
select [Save as…] . Give the file any name you prefer. 
 
3. Each section on the form was created as a table; therefore, if extra space is required 
when typing, the vertical space in the text portion of a section will increase as you type.  
To begin a new paragraph when typing text, simply hit a hard return [Enter].  If you 
desire to indent paragraphs in text typing, use a control tab [Ctrl] [Tab].  
 
4. After completing the form, you may want to remove excess hard returns between 
sections in order to limit the finished protocol form to a minimum number of pages.  
 
5. Should you encounter any problems while using this form, please contact Nancy, David 








Pennington Biomedical Research Center 
PROTOCOL FOR ANIMAL CARE AND USE 
 
Submission Instructions: MUST BE TYPED!  (Use additional sheets if necessary and 
attach to this form).  SUBMIT ORIGINAL plus 10 COPIES to the IACUC Office, Rm. 
B1022 (Dr. David York’s office) 
 
 
SECTION 1: Investigators 
Principal Investigator: 
















SECTION 2: Project Title (Enter the title of your project in the block below.) 
NUTRITION, STRESS AND BODY WEIGHT REGULATION 
 
 
SECTION 3: Investigator’s Statement reguarding the Assurance for the Humane Care and 
Use of Vertebrate Animals. 
By signing this form, we agree to abide by Pennington Biomedical Research 
Center’s Policy for the Care and Use of Animals.  This project will be in accordance with the 
NIH “Guide for the Care and Use of Laboratory Animals” (except as explained in the 
accompanying protocol), and the PBRC Animal Welfare Assurance on file with the U.S. 
Public Health Service. 
I further assure the Committee that: 
1) I will abide by all federal, state, and local laws and regulations governing the use 
of animals in teaching and research. 
2) The investigators and technicians are or will be adequately trained to perform the 
research techniques required in these studies. 
3) I will use the fewest number of animals required to produce the appropriate 
statistical power for this study. 
4) The research proposed herein is not unnecessarily duplicative of previously 
reported research. 
5) For those completing Section 13.2 and 13.3:  I have reviewed the pertinent 
scientific literature and the sources and/or databases as noted in Section 13, and 
have found no valid alternative to any procedures described herein which may 
cause more than momentary pain or distress, whether it is relieved or not. 
 
Roy J. Martin Professor 10-31-02 
Type Name of Principal Investigator  Title/Rank Date 
   
Principal Investigator Signature   
David S. Roane Adjunct professor 10-31-02 
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Type Name of Co-Investigator Title/Rank Date 
   
 Co-Principal Investigator Signature   
 
SECTION 4: Animal Species 
 
Species: Rat Strain: Sprague-Dawley rats and Zucker rats  
Sex:  male  female  either   
both 
Weight (or age for rodents): 200~250g(SD 
rats) 5 weeks (Zucker rats) 
 
Species:       Strain:       
Sex:  male  female  either   
both 
Weight (or age for rodents):       
 
Species:Rat        
Number of animals needed:  950        
Year 1: →470        
Year 2: →240        
Year 3: →240        
TOTAL: →950        
Maximum # needed at one time: 100        
 
 
Animal housing and veterinary care must be coordinated with Comparative Biology. 
Signature of Comparative Biology Representative 
(required): 





SECTION 5: Abstract Plan of Research/Teaching (Provide a brief layman’s description 
of the project.  This information will help the animal care staff to understand any conditions 
encountered while caring for your animals.  This space will expand as you type.) 
The overall goals of the present research plan are as follows:  
 
1)identify the neurochemical and physiological mechanisms of stress, hunger, satiety and spontaneous 
anorexia associated with maintenance of body weight and composition. 
2)identify nutritional interventions that modify or prevent a) weight gain or regain, b) stress-induced and 




SECTION 6: Special Husbandry Requirements 
Do your animals have special needs to be addressed by Comparative Biology?   Yes
  No 
 
If yes, please complete each section that is different from the standard of care for rodents. 
The standard of care is: plastic shoebox, corn cob bedding, rodent chow, ≅21-22°C room 
temperature, ≅55% humidity, and tap water. 
 
TEMPERATURE RANGE 21-22o  (C) Humidity: 55  (%) 
LIGHT CYCLE (hours light/hours 
dark) 
12:12 
CAGING Type: wire hanging Size: standard Filter tops required? No 
BEDDING/LITTER Type:       Autoclaved?       Changes/week:       
WATER Sterile:       De-ionized: 
      
Acidified: 
      
Tap: Yes Other:       
DIET Special Feeding Requirements: In experiments 9,10, and 11, rats will be tube fed 
with a commercial semi-purified diet.  Dr. Jun Zhou will train graduate student (Bing 
Li) and student work for this type of special feeding procedure. 
 
IF USING WIRE BOTTOM 
CAGES, PLEASE 
JUSTIFY: 
 Food intake and spillage need to be measured during the experiment 
period. 
 




SECTION 7: Hazardous Materials  Will zoonotic or recombinant, radioactive, or 
hazardous chemical agents be PRESENT IN THE ANIMAL ROOM? 
 
Zoonotic/Recombinant Agents Radioisotopes Hazardous Chemicals 
 YES  NO 
 
Agent(s):____________       
 EXEMPT 
 
IBRDS Chairman Signature: 
   
 YES  NO 
 
Are you certified by the 
Radiation Safety 
Committee? 
 YES   NO 
 
Isotope(s):        
 YES  NO 
 
If yes, you must complete the 
Hazardous Chemical Form 
(Appendix A) 
 
Compound(s):      
Note: If zoonotic (infectious to humans) or recombinant organisms are to be used, 
this protocol request must be submitted to the Biohazardous Materials Safety Committee 
for approval PRIOR TO CONSIDERATION by the IACUC. Similarly, if hazardous 
chemicals are to be used in the animal room, submit the proposal to the Chemical Safety 
Committee for prior approval. P.I. MUST PROVIDE health and safety measures for 
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animal technicians and facility maintenance personnel. In Standard Operating Procedure 
(SOP) form, describe any precautions, procedures, or personal protection required in 
handling animals or waste containing listed agents or compounds, or in working in or 
around the animal room (including air handling system), and attach a copy of your 




SECTION 8: Type of Project (check the appropriate box) 
 TYPE A - Pain or distress will not be induced; animals will only be used for 
injections, collections, or procedures causing nothing more than minor discomfort; or 
will be humanely euthanized prior to induction of pain or distress. 
 TYPE B - Pain or distress will be relieved by appropriate therapy 
 TYPE C - Drug intervention for pain or distress would interfere with the protocol.  (If 
this block is checked, specific justification MUST be provided in the box 
below.)  
      
 
 
SECTION 9: Summary of Procedures 
Answer each of the following in the box provided.  If a section is not applicable, indicate not 
applicable.  Your response in this section should provide the reader with a complete 
description of how every animal to be used in this project is to be treated during every 
phase of the study. Your target audience is a faculty member from a discipline unrelated to 
yours. Do not use jargon.  Please include the following information: (each box will expand 
as needed, as text is added) 
 
9.1. Rationale: The rationale for using animals.  Why should this study be done?  What 
hypothesis/es will be tested? 
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Experimental Series I will focus on analysis of potential glucose sensing genes and proteins in the 
CNS.  Specifically, these experiments will test the hypotheses that: 1) Glucose sensing gene and 
proteins are co-localized within the same cell in the brain much like pancreatic islet cells.  2) 
Intracerebroventricular streptozotocin treatment will reduce the number of cells co-localizing 
glucose sensing proteins.  Experiment 1, 2a, and 2b will address hypotheses 1) and 2) respectively. 
 
 Experimental Series II will focus on peptides and neurotransmitters related to ingestive 
behavior and their interactions with glucose sensing cells in the brain.  Specifically these 
experiments will test the hypotheses that: 1) Streptozotocin will decrease glucoprivic induced 
hyperphagia, decrease the glucosensing ralted gene expression, and decrease glucosensing related 
peptides contents in the brain. 2) Streptozotocin will attenuate the behavioral response to centain 
ingestive peptides and neurotransmitters that are glucose related. 3) Streptozotocin will decrease 
the in vitro neurotransmitter release stimulated by glucoprivation.  4) Streptozocin will decrease 
the hypoglycemia induced by the hypothalamic administration of glibenclamide.  Experiment 3, 
4a, 4b, 5, and 6 will test these hypotheses respectively. 
   
 Experimental Series III will test the hypotheses that glucose-sensing mechanisms in 
specialized cells of the brain are altered by obesity, by glycemic state, and by simple states of 
hunger and satiety.   Three robust models of disrupted energy balance and glucose homeostasis will 
be used.  Each model has a different etiology.  Fatty Zucker rats, over-/underfeeding rats, and 
glucose/5-thioglucose intracerebroventricular injected rats will be used in this experiment series.  
We will test these rats’ behavioral responsiveness to glucoprivation/glucose excess and correlate 
these changes with levels of brain glucosensing genes expression in experiment 7, 8, 9 and 10. 
 
 Collectively, these experiments will explicitly test whether specialized glucose sensing 
cells in the brain play a role in the physiological control of feeding behavior and glucose 
homeostasis.      
 
9.2. Species Selection: How and/or why you selected the animal species indicated? 
Most of the basic mechanisms of brain regulation of body weight and energy balance are studied in 
rats and mice.  In addition, it is more economical to use the smaller species of animals at this level 
of investigation.  Once a critical factor is identified for body weight regulation it will be tested in 
larger species and eventually in human trials after safety concerns are addressed.   
 
9.3. Experimental Design: A complete description of the proposed use of the animals.  
Describe the experimental design of the study.  Include a list of any physical, chemical 
or biological agents (name, dose, volume, route, and frequency) that may be 
administered.  Tables and outlines are helpful to indicate group assignments and 
study progression. 
Table 1. Number of animals required 
-----------------------------------------------------------------------------------------------------------------------
--- 




1       50                Based on power analysis of preliminary data, alpha=0.05, 
beta=0.80 
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2a       60                Empirically based on professional judgment with similar 
experiments 
2b       60                Empirically based on professional judgment with similar 
experiments  
3       80                Empirically based on professional judgment with similar 
experiments 
4 a      100               Adequate number for establishing clear dose/ response 
relationships 
4 b      100               Adequate number for establishing clear dose/ response 
relationships 
5       40                Based on power analysis of preliminary data, alpha=0.05, 
beta=0.80 
6       80                Empirically based on professional judgment with similar 
experiments 
7 40 Zucker rats    Empirically based on professional judgment with similar 
experiments 
8 64  
        male Zucker rats     Empirically based on professional judgment with similar 
experiments 
9      60                 Empirically based on professional judgment with similar 
experiments 
10      60                 Empirically based on professional judgment with similar 
experiments 
11      60                 Empirically based on professional judgment with similar 
experiments 
12      48                 Empirically based on professional judgment with similar 
experiments 
13      48                 Empirically based on professional judgment with similar 
experiments 
Total rats number 950  
-----------------------------------------------------------------------------------------------------------------------
---   
Experiment 1.   Are cells in the brain expressing the same genes and proteins found in 
the     islets of Langerhans.   
        This study will use in situ hybridization and immunohistochemical techniques 
to localize cell populations that co-localize components of the pancreatic glucose-
sensing machinery.  Total number of 50 Spraquely-dawley rats will be used. Half 
of the rats will be used for in situ hybridization to examine glucosensing gene 
expression.  The other half will be used for immunohistochemistry to test 
glucosensing protein levels 
                   For in situ hybridization, rats will be killed by decapitation.  The whole brain 
will be collected and snap frozen on dry ice and stored at  -80°C until be sectioned 
on a cryostat.  For immunohistochemistry, rats will be euthanized with an overdose 
of pentobarbital and each rat will be perfused transcardially with heparinized, 
phosphate buffered saline (~ 150 ml) followed by cold phosphate buffered, 4% 
paraformaldehyde at 4° C.  The brain is removed and postfixed in a 20% 
sucrose/4% paraformaldehyde solution overnight.  The brain is then ready for 
section on a cryostat.   
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Experiment 2.  Streptozotocin destruction of CNS glucose sensing elements.  
                   One hundred and twenty Spraque-Dawley rats will be anesthetized as 
described in general anesthesia procedure below, and then placed in a stereotaxic 
apparatus.  Sixty rats will be fitted with third ventricle cannula (experiment 2a) and 
the rest will be fitted with 4th ventricle cannula (experiment 2b).  The detailed 
methods for insertion of cannula are described under the "General method for 
brain cannulation” below. Rats will be food deprived for 12 hours prior to injection 
of streptozotocin (100ug in 5 ul vehicle) or vehicle(5 ul of a freshly made buffer 
containing 120 mM NaCl and 20 mM NaHCO3, pH 7.2-7.4). Streptozotocin or 
vehicle will be injected into the 3rd or 4th ventricle by connecting cannula interal 
with Gastight syringe though polyethylene tubing. The injection rate will be 
1ul/3minutes. The cannulae are then closed and the animal will be placed in a 
warmed cage to recover.  Each animal is allowed to recover for 4 to 10 days after 
streptozotocin injection. After recovery, each animal will be decapitated or 
euthanized by an overdose of pentobarbital and perfused (for in situ hybridization 
and for immunohistochemistry respectively, as described in experiment 1). The 
pattern of staining is then compared between the vehicle and streptozotocin 
treated rats.    
   
Experiment 3: Streptozotocin will decrease glucoprivic-induced hyperphagia. 
        Eighty Spraque-Dawley rats will be treated with streptozotocin or vehicle as 
described in experiment 2.  We will choose either 3rd or 4th ventricle cannulation 
depending on the results of experiment 2.  After a 4 to 10 day recovery period, half 
of the rats in each group will be evaluated for behavioral response to a glucoprivic 
challenge (200 mg/kg 2DG, i.p) and the other half will have saline injection as 
control.  Food intakes will be measured at the time point of 30, 60, 120, and 240 
minutes after injection.  This challenge will allow us to determine that the 
streptozotocin treatment was effective.  Following the behavioral test to a 
glucoprivic challenge (3-5 day recovery period), rat will be killed to examine 
ingestive relate peptides and their gene expression by immunohistochemistry or in 
situ hybridization as described in experiment 1.  Distribution of staining for the 
ingestive peptides or the respective receptors will be compared between the 
vehicle and streptozotocin treated rats. 
 
Experiment 4:  
        Two hundreds SD rats will be placed 3rd or 4th ventricle cannulae depending 
on the results of experiment 2.  After 7 to 10 days recovery, the rats will be treated 
with streptozotocin or vehicle as described in experiment 2. Behavioral tests will 
be conducted 4~7 days after streptozotocin injection.  The behavioral tests will 
include a glucoprivic challenge, as described in experiment 3, to determine 
efficacy of the streptozotocin.  We will also use 12 h food deprivation to stimulate 
food intake in these rats.  The following peptides and neurotransmitters will be 
tested on altering deprivation induced feeding in rats treated with streptozotocin.  
We also will develop dose-response curves for each of the peptides and 
neurotransmitters according to the table below.  The injection volume will be 5ul 
and the freshly made buffer (120 mM NaCl and 20 mM NaHCO3, pH 7.2-7.4 ) will 
be used to prepare the injection solutions.  Due to the difficulty of handling such a 
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large number of cannulated rats, we will subdivided this experiment in two parts. In 
the experiment 4a, we will test GLP-1, Amylin, and Leptin.  In the experiment 4b, 
we will test NPY, CRH and GABA .  One hundred rats (50 for vehicle and 50 for 
streptozotocin) will be used in each experiment; each dosage group will have 10 
rats.  Food intakes will be measured at the time point of 30, 60, 120, and 240 
minutes after injection. 
-----------------------------------------------------------------------------------------------------------------------
--- 
          PEPTIDE   EFFECT       DOSES 
-----------------------------------------------------------------------------------------------------------------------
--- 
         GLP-1                         Suppress food intake              0, 0.5, 1, 5, 10 ug 
         Amylin                         Suppress food intake     0, 1, 10, 25, 100 ug/kg 
         Leptin                         Suppress food intake              0, 1, 10, 25, 100 ug/kg 
         NPY                         Increase food intake              0, 1, 10, 25, 100 ug/kg 
        CRH                         Suppress food intake              0, 1, 10, 25, 100 ug/kg 
        GABA                         Increase food intake              0, 1, 10, 25, 100 ug/kg 
-----------------------------------------------------------------------------------------------------------------------
--- 
Experiment 5:  
        Forty SD rats will be treated with streptozotocin or vehicle as described 
above. Seven days after the treatments, brains will be quickly removed by 
decapitation, and placed in a slicing block.  Based on immunocytochemistry and in 
situ hybridization studies in experiment 1, brain areas that express GLUT-2 and 
Glucokinase will be dissected, weighed and placed in appropriate chambers of a 
Brandel Superfusion 2000 apparatus.  Tissues will be superfused at 0.1 ml/min 
with Kreb's Ringer bicarbonate buffer (KRB) with the following composition in mM: 
NaCl 118.6, KCl 4.8, CaCl2 2.5, KH2PO4 1.2, MgSO47H2O 1.3, NaHCO3 24.6, 
glucose 33 and pargyline 0.4, a monoamine oxidase inhibitor.  KRB is used to 
collect "basal" release.  Basal release will be collected for 90 minutes.  Then, KRB 
containing 10 mM 2-DG will be perfused to stimulate neurotransmitter release 
("stimulated" release) for 5 minutes.  Stimulated release is carried out to check for 
viability of the tissue.  The flow rate will be 100 ul/minute.  The eluate from each 
chamber is collected at 5-minute intervals with a fraction collector.  An internal 
standard is added to each sample as it is collected. Samples are immediately 
frozen on dry ice and stored at -70°C until analysis via HPLC.  
 
Experiment 6:   
        Eighty SD rats will be fitted with bilateral cannula targeted for drug delivery to 
the dorsal aspect of the ventromedial nucleus of the hypothalamus. Following a 
seven-day recovery period, half of the animals will be bilaterally injected with of 
streptozotocin as decribed in experiment 2, but injection volume will be reduced to 
2ul each site. The remaining animals will receive injections of vehicle. Four days 
later, half of the animals in each treatment group will be injected with 1 nmol(2ul) 
of glibenclamide through each cannula and the remainder will be injected with 
solution used for preparation of the glibenclamide (see below). A 30ul blood 
sample will be collected by tail bleeding (see “General method for tail bleeding”) 
immediately before and every 15 minutes after glibenclamide injection, for a period 
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of one hour. Blood glucose will be measured by glucometric analysis.  
        As glibenclamide has limited aqueous solubility, it will initially be dissolved in 
very small quantities of DMSO.  The solution will then be brought up to near final 
dilutions in a freshly made buffer containing 25 mM NaCO3, 100 mM NaCl, 4 mM 
KCl and 1 mM glucose. Final pH will be adjusted to 7.2 with 0.1 N HCl.  Control 
animals will be injected with the drug vehicle (including DMSO, 0.2 to 10%). 
        The weakest point of this approach is probably that of injecting each animals 
through the VMH cannula twice. Any amount of injection is likely to produce some 
cell damage and hence introduce that possibility of artifact. None-the-less, we feel 
this is a necessary risk given the poor (or unknown) diffusion capacity of 
streptozotocin through the parenchyma of the brain. If streptozotocin was given by 
a ventricular route, it might not reach the critical areas in concentration sufficient to 
produce meaningful biological results in the area in question. 
 
Experiment 7.  
        We will kill 20 lean and 20 obese Zucker rats (8 weeks old) and collect brains 
for studies of CNS and pancreatic gene expression of proteins involved in glucose 
sensing based on results of experiment 1 and 2. Half of the rats in each phenotype 
will be used for in situ hybridization to examine glucosensing gene expression.  
The other half will be used for immunohistochemistry to test glucosensing protein 
levels.  The detailed methods for brain tissue collections are the same as in the 
experiment 1. 
            
Experiment 8.    
                     Sixty-four male Zucker rats, half lean, half obese and aged 6 weeks, will be 
injected glucose.  Since we have validated that 2.5 gm of glucose will suppress food 
intake in hungry Sprague-Dawley rats and that streptozotocin will attenuate this response, 
we will conduct a glucose dose response curve (0, 1.0, 1.5, and 2.5 gm glucose in 0.5 ml 
saline solution, i.p.) in both lean and obese rats. Each dosage group will have 8 rats and 
each rat will be tested repeatedly at age of 6, 8, 10, and 14 weeks  
 
Experiment 9. Does over- and under- feeding models alter CNS cells of glucose sensing?  
                    Sixty Sprague-Dawley rats, weighing about 250 grams, will be randomly 
assigned into four groups (n=15 per group). One group will be ad libitum fed as an 
ad lib intake control group; the other three groups will be tube fed. In tube fed 
groups, one group (regular fed) will be tube fed 85% of ad lib food intake, the 
second group (underfed group) will be tube fed 50% of ad lib food intake, and the 
3rd group (overfed group) will be tube fed 150% of ad lib food intake. As tube 
feeding 85% of ad libitum food will cause body weight gain similar to ad lib feeding 
rats according to our previous study, 85% fed group will be used for normal regular 
fed control in tube fed rats for comparison. Four parts of a commercial semi-
purified diet, which contains 70% polycose, 10% casein, 10% coin oil, 3% 
cellulose, and 1% AIN vitamin and mineral mix, will be mixed with three parts of 
warm water to make a liquid diet. The rat will be restrained with the right hand and 
the feeding tube will be gently introduced through the mouth into the stomach. The 
freshly prepared meal (5 ml) will be gently delivered from syringe and then the 
tube will be withdrawn. The amount of food delivered to overfed and underfed rats 
will be gradually adjusted to the desired level of intake over a period of 3-5 days. 
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The rats will receive one-third the daily amount of food, three times daily (07:00, 
14:30, and 22:30) for 14 days. Body weight will be recorded daily before the 07:00 
feeding.  
                    This model has the advantage of having a controlled rapid alteration of 
adipose tissue mass and the up-regulation of either hunger or satiety signals, thus 
making it easier to measure changes in gene expression.  In addition, since weight 
gain or weight loss is produced without changing diet composition and in animals 
of the same genetic background, there are fewer confounding factors to consider.  
Furthermore, the exact caloric intake, meal size and timing can be controlled, 
further reducing variability.  At the end of the study, rats will be decapitated, brain 
and pancreatic tissues will be removed for RNA and protein extraction.  Real-time 
PCR and westerns will be used to identify gene expression and proteins that are 
altered in positive and negative energy states.  The gene expression we target will 
be based on results found in the experiment 1 and 2. Specifically those mRNA and 
proteins that are reduced or eliminated by streptozotocin treatment.   
 
Experiment 10.  Does obesity caused by hyperphagia alter feeding response to 
glucoprivation by altering CNS cells of glucose sensing? 
         Sixty Sprague-Dawley rats, weighing about 250 grams, will be placed 3rd 
ventricle cannula (see General method for brain cannulation” below).  After 7 to 10 
days recovery, the rats will be randomly assigned into two groups (n=30 per 
group). One group will be tube fed 85% of ad libitum food and the other group will 
be tube fed with 150% of ad libitum food.  The amount of ad libitum food will be 
determined according to the results of Experiment 9. The diet composition and the 
feeding method are the same as those described in Experiment 9.  After 14 days 
tube feeding, rats in each group will be divided into two subgroups: control and 2-
DG.  Control group will be ICV injected with vehicle (5 ul of a freshly made buffer 
containing 120 mM NaCl and 20 mM NaHCO3, pH 7.2-7.4) and 2-DG group will 
ICV injected with 2-DG (10ug in 5ul of vehicle).  Food intake will be recorded at 1h, 
2h, and 4h after ICV injection.  All rats will be killed four hours after injection, for 
the measurement of glucosensing related gene expression and protein as 
described in Experiment 1 and Experiment 9. 
 
Experiment 11.  Does energy deficiency caused by underfeeding alter feeding response 
to glucose by altering CNS cells of glucose sensing? 
          Sixty Sprague-Dawley rats, weighing about 250 grams, will be placed 3rd 
ventricle cannula (see “General method for brain cannulation” below).  After 7 to 
10 days recovery, the rats will be randomly assigned into two groups (n=30 per 
group). One group will be tube fed 85% of ad libitum food and the other group will 
be tube fed with 50% of ad libitum food.  The amount of ad libitum food will be 
determined according to the results of Experiment 9. The diet composition and the 
feeding method are the same as those described in Experiment 9.  After 14 days 
tube feeding, rats in each group will be divided into two subgroups: control and 
glucose.  Control group will be ICV injected with vehicle (5 ul of a freshly made 
buffer containing 120 mM NaCl and 20 mM NaHCO3, pH 7.2-7.4) and glucose 
group will ICV injected with glucose (10ug in 5ul of vehicle).  Food intake will be 
recorded at 1h, 2h, and 4h after ICV injection.  All rats will be killed four hours after 
injection, for the measurement of glucosensing related gene expression and 
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protein as described in Experiment 1 and Experiment 9. 
 
Experiment 12.  Long-term hyperglycemia in brain stem area (including AP/NTS) through 
fourth ventricle infusion of glucose. 
           Forty-eight male SD rats will be will be placed 4th ventricle cannula (see 
“General method for brain cannulation” below).  Following complete recovery from 
surgery (rats will be considered to have recovered with the return to preoperative 
food intake level and body weight), an Alzet pump, containing test solution, will 
replace in the peritoneal cavity and connected with the brain cannula on each rats 
(see “General method for Alzet pump” bellow).  The rats will be divided into 4 
groups according to the following table. This system will deliver our test solution to 
the 4th ventricle areas at a rate of 0.5 ml /hr for 14 days.  Food intakes and body 
weight will be measured during the experiment period and at the end of 
experiment, all rats will be killed for measurements of glucosensing related gene 
and protein as described in experiment 1   
-----------------------------------------------------------------------------------------------------------------------
---      
 Treatments                                            Number of Animals                        . 
-----------------------------------------------------------------------------------------------------------------------
--- 
 Control  Mock CSF fluid    12 
            Experimental  (plus glucose)      
         5  mM    12 
       20  mM    12 




Experiment 13.  Long-term hypoglycemia in brain stem (including AP/NTS) through fourth 
ventricle infusion of 5-thioglucose. 
           Forty-eight male SD rats will be will be placed 4th ventricle cannula (see 
General method for brain cannulation” below).   Following complete recovery from 
surgery (rats will be considered to have recovered with the return to preoperative 
food intake level and body weight), an Alzet pump, containing test solution, will 
replace in the peritoneal cavity and connected with the brain cannula on each rats 
(see detailed method for Alzet pump bellow).  The rats will be divided into 4 groups 
according to the following table. This system will deliver our test solution to the 4th 
ventricle areas at a rate of 0.5 ml /hr for 14 days.  Food intakes and body weight 
will be measured during the experiment period and at the end of experiment, all 
rats will be killed for measurements of glucosensing related gene and protein as 
described in experiment 1   
-----------------------------------------------------------------------------------------------------------------------
-- 
 Treatments      Number of Animals *                     
-----------------------------------------------------------------------------------------------------------------------
-- 
 Control  Mock CSF fluid               12 
 Experimental 5-thioglucose     
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                             5.0 mM     12 
     20.0 mM     12 
                100.0 mM     12               .                      
 
 
9.4. Number of Animals: How did you arrive at the number of animals to be used. (In 
other words, is this number required to (reach) obtain sufficient statistical power, or 
necessary as a continual source of tissue harvest for ongoing work, or a limited 
number for pilot or feasibility studies, or other.) This may be best accomplished by use 
of a table. 
The number of animals used in each experiment is based on a power analysis.  Since the standard 
deviation of the different measurements determines the number of rats to be used in the above 
considerations and the standard deviation varies with different measurements, it is necessary that 
adjustments be made in the estimate of animals needed on each trial as we gain experience with 
some of these measurements.  Usually it requires 8-10 rats per treatment group with 3 to 4 
treatment groups per study.  For the brain cannulation, 12-15 rats per group will be needed. Studies 
typically last approximately 6 weeks.  
 
9.5. Non-Surgical Procedures:  Describe each procedure to which any animal in any 
group may be subjected.  Indicate how analgesic, anesthetic, and tranquilizing agents 
will be used where appropriate, to minimize discomfort and pain to the animals.  It is 
advisable that you obtain input from PBRC’s Attending Veterinarian (Dr. David Baker). 




9.6. Surgical Procedures/Ante Mortem Tissue Harvest (complete questions 6 a-i if 
animals survive surgery/tissue harvest.  Only sections a-f should be completed if non-










General method for Alzet pump 
 The Alzet mini-osmotic pump(Alza, Stanford, CA, model 2002: 0.5ul/hr for 14 
days) will be filled with the appropriate test solution described in each experiment 
and placed in 0.9% saline at 37°C overnight.   The primed pumps will then be 
placed subcutaneously in the rats under isofluorane anesthesia.  A small incision 
will be made in the scapulae region of the back, where the pump will be placed.  
Each incision is closed with suture. The combined uses of mini-osmotic pumps 
and brain cannulation have been successfully utilized in our lab in the study of 
obesity. Chronic infusion of test solution into brain will be accomplished by 
connecting outlet of the mini-pump to an infusion cannula (designed to project 1 
mm beyond the guide cannula tip) through silicone tubing (Baxter/Scientific 
Products) filled with test solution.  This system will deliver our test solution to the 
fourth ventricle at a rate of 0.5 ml /hr for 14 days.  
 
General method for brain cannulation: 
 Rats will be anaesthetized with Ketamine/Xylazine/Acepromazine mix (80 mg/Kg 
Ketamine, 6 mg/Kg Xylazine, 2mg/Kg Acepromazine SQ injection).  They will be 
placed in the stereotaxic apparatus. An incision will be made along the midline 
and periosteum will be scraped from the skull, while a combination of lidocaine 
and bupivicaine (1:1 dilution) is infiltrating on the cranium.  Site-specific guide 
cannula (Plastics One Inc., VA) will be placed. Third ventricle 22 G guide cannula 
will be placed using the following coordinates from the bregma: 2.8 mm posterior, 
0 mm lateral, 8.1 mm deep.  Fourth ventricle 22 G guide cannula will be placed 
using the following coordinates from the occipital suture: 2.5 mm posterior, 0 mm 
lateral, 4.5 mm deep.  VMH 22 G guide cannula will be placed at 13 degrees using 
the following coordinates: 2.8mm behind Bregma and 2.8 mm to the right (or left) 
of Bregma.  The cannula connectors will be fixed to the skull with jewelers screws 
and cyanoacrylate gel (plastic One).  31G injectors will extend 1 mm below the 
guide cannula.  
 Placement of ventricular cannula will be verified by measuring angiotensin II 
response.  After a 5-day recovery period, the rats will be injected angiotensin II 
(150ng in 3ul 0.9% saline) through the cannula and those exhibiting a negative 
drinking response will be excluded. Placement of site-specific cannula will be 
confirmed histologically by injected with 0.25 ul India ink and killed 4 minutes 
later.  Brains will be fixed in formalin and the location of the injection sites 
confirmed histologically.  The rats will be allowed to recover from surgery for one 
week and then baseline food intakes and body weights will be recorded.  Food 
intakes and body weights will be recorded through out the experiment period.   
 
General method for tail bleeding: 
 Blood is collected in hand-held, conscious rats by tail bleeding.  A small section 
(2-3mm) is nicking from the end of the tail and 30 to 50 ul blood is collected in an 
eppendorf tube within less than 2 minutes.  A simple gauze will be applied to the 



































































e harvest is 
performed: 
PBRC Comparative biology surgery room 
Drug: #1 - Ketamine/acepromazine/xylazine 
#2 - 0.25%Bupivacaine/Lidocaine 
Dose: #1 - 80/2.0/6.0mg/kg 
#2 - 2.5~12.5 mg/kg or 1:1 dilution  
Frequency: #1 - Once 
#2 - Once 
9.6.d) Anesthesia: 
(Duplicate 
table if more 
than one 








#1 - SQ 
#2 - infiltrating the periosteum at the site where 
trephining will occur 
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1. First 24 hours: put rats in a warm place and observe rats until they 
are conscious 
2. Second 24 
hours: 
obeserve rat's behavior, body weight, and food 
intakes 






3. Thereafter: obeserve rat's behavior, body weight, and food 
intakes  
Drug: Tylenol 
Dose: 110~300 mg/kg body weight (1:1000 dilution) 



























  YES 
  NO 
If yes, please provide justification.  The combined use of 
mini-osmotic pumps and brain cannulation can chronicly 
infusion of test solution into certain site of the brain.   
 
9.7. Euthanasia:  What method or agent will be used to sacrifice the animals?  Include 
dosage and route of administration. 
Method: Animals will be euthanized at the end of the experiment by rapid 
decapitation.  Due to the nature of the biochemical measurements to be 
performed, this must be carried out without anesthesia.  Decapitation will 
be carried out by individuals who have had previous training and 
experience with the procedure and can minimize stress to the animal. 
Drug:       
Route of Administration:       









Provide justification for why the action is needed. The information you provide in this 
section is very important in highlighting specific points of your study that are important 
considerations for the IACUC in their review process.  
YES NO Question Response to Question 
    No ← .. Will animals be restrained?  (Restraint refers to 
immobilization or other restrictions to normal 
movement beyond momentary holding for 
injections, etc.) 
 
  If so, how?  ................................................ →       
  Who is the individual responsible? ................
 → 
      
Yes     ← .. Will animals be fasted?  
  Is yes, for how long? ......................................
 → 
50% feeding for 14 days 
Yes     ← .. Do you anticipate any adverse effects of the 
experimental procedures on the animals?  
 
  If yes, list the conditions (e.g., pain, discomfort, 
% weight loss, maximum tumor size, fever, 
miminum packed cell volume, etc) ..................
 → 
weight loss  
    No ← .. Is death an endpoint in your experimental 
procedure?  Note: Death as an endpoint refers 
to acute toxicity testing, assessment of virulence 
of pathogens, neutralization tests for toxins, and 
other studies in which animals are not 
euthanized, but die as a direct result of the 
experimental manipulation.  
Not Applicable 
    No ← .. Are there emergency treatments by the 
Comparative Biology veterinary staff that would 
not be allowed? 
 
  If yes, list the treatments. ...............................
 → 
      
    No ← .. Are you using wild or exotic species for which 
permits are necessary?  (ATTACH COPY) 
Note: Permits are required for protocol approval.
Not Applicable 
    No ←...Will animals be used for antibody production? Not Applicable 
    No ← .. Will Complete Freund’s Adjuvant be used?  
  If yes, please justify based on scientific reasons.  
→ 
      
    No ← .. Will other adjuvants be used?  
  If yes, please specify. .....................................
 → 
      
Yes     ← ..Will blood be collected? If yes: (Note: Blood 
equal to 1.5% of the animal’s body weight per 2 
weeks represents the upper approvable limit, 
unless scientific justification is provided.) 
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  How often? .........................................................
...→ 
Once or twice depending on 
particular experiment 
  Volume? .........................................................
...→ 
0.05ml for tail bleeding 
  Who will collect blood? ...................................... → Jun Zhou,  Iwona Bogaka, 




SECTION 11: Animal Management 
 
11.a) Individual (or groups of) animals are identified by (i.e. tag, 
tattoo): 
Cage card 
11.b) Check all applicable below: 
CARE OF SICK ANIMALS DISPOSAL OF DEAD 
ANIMALS 
PEST CONTROL 
 Call Investigator 
 Clinician to Treat 
 Euthanasia 
 Call Investigator 
 Necropsy 
 Disposal.  List any special 
requirements for 
disposal?      
 Call Investigator 
 Pesticides OK 




SECTION 12: Disposition of Animals  (What will be done with any animals at the 
conclusion of the project? Check the appropriate box.) 
 Animals will be euthanized. 
 Comparative Biology has permission to REASSIGN animals to another IACUC-
approved protocol. 
 TRANSFER animals to the following IACUC-approved protocol(s).  Protocol 
Number:       




SECTION 13: Narrative Statement 
Federal regulations mandate that you provide written, narrative statements for all 
projects: 
 
13.1. that the activities do not unnecessarily duplicate previous experiments.  In this 
statement, include sources used to make such a determination (e.g., Databases, 
workshops, expertise in the field, etc 
Source:Electronic database 
If your source is an electronic database(s), complete the following boxes. 
Date Search Completed: 10-31-02 
Database(s) Searched: Medline 
Keywords:  obesity, food intake, satiety peptides, streptozotocin, glucose signaling, brain, 
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central nervous system, brain metabolism; attendance at scientific meetings where discussions 
of regulation of food intake and obesity are held. 
Years covered in search: 1966~ present 
 
Note:  Answer 13.2 and 13.3 if you indicated Type B or C in Section 8. 
13.2. that you have considered alternatives to procedures producing more than 
momentary or slight pain or distress.  Indicate what those alternatives were and why 
they are not appropriate. 
there are no alternatives to the procedures in this proposal  
 
13.3. describing the methods you used to determine that alternatives to such 
procedures were not available. Put your statements in the block below. 
Source: Electronic database 
If your source is an electronic database(s), complete the following boxes. 
Date Search Completed: 10-31-02 
Database Searched: Medline 
Keywords: obesity, food intake, satiety peptides, streptozotocin, glucose signaling, brain, 
central nervous system, brain metabolism; attendance at scientific meetings where discussions 
of regulation of food intake and obesity are held. 




SECTION 14: Investigator Training 
In accordance with IACUC policy, all personnel conducting animal-based research must 
attend a Rules and Regulations Course and verify their training, experience and skills in the 
care and use of the animals and techniques they are responsible for. 
 





If no, who will do 
training? 
David S. Roane  YES  NO       
Jun Zhou  YES  NO       
Iwona Bogacka  YES  NO       
Bing Li/Xiaochun Xi  YES  NO  
 
 
NOTE:  All personnel must complete Comparative Biology’s training course in order to have 





Hazardous Chemical Form 
 for Chemical Use in Animal Rooms 
 
This form should be completed for all studies in which hazardous agents (e.g., toxic chemicals, or 
carcinogens) are to be administered to animals that are expected to survive following exposure.  A 
separate form must be submitted for each hazardous agent used.  This form must be approved prior to 
starting a study. 
 
INVESTIGATOR:                                                PHONE:                                   IACUC 
PROTOCOL#: _________                     
 
Compound to be administered (please attach MSDS):    
 
 
Site of compound dose preparation and brief description of containment (safety measures including 
hood, gloves, etc.):  
 
                                                                                                                                                                                           
Concentration administered:    
 
                                                                                                                     
Location of compound storage and conditions of storage:  
                                                                                                                                                                                           
Degree of health hazard to humans (circle the most appropriate number): 
 
                                                              
  LOW 1       2        3                  4     5      HIGH 
 
1 = no special precautions required                                   5 = extreme 
precautions required 
 
Assays/Assessment to determine exposure to animal or personnel:                                                                                  
 
Species to be used:                                                                        Strain: 
__________________________                                                  
 
Route of administration:                                                                Dose: 
___________________________                                                  
 
Duration of administration:   
                                                                                                                           
Note the anticipated morbidity (          %) and mortality (          %) if known. 
 




                                                                                                                                                                                
Maximum number of exposed animals that will be maintained at one time:    
 
                                             
Indicate the experiment endpoint:  
                                                                                                                 
The following personal protective equipment must be used in the room: 
 
  Lab coat/Coveralls  NIOSH Certified Dust Mask  Fitted Respirator with HEPA filters 
  Shoe covers/booties  Disposable gloves  Latex     
  Nitrile gloves                   Other: 
______________________________________________________ 
 
 NOTE: Short pants, skirts, and dresses may not be worn in the animal room. 
 
Other relevant information or procedures: include 1) additional precautions, 2) emergency treatments 
for exposed personnel, 3) decontamination procedures for equipment, 4) housing areas, 5) personnel, 
6) how to determine if personnel are or are not exposed: 
 
 








Do animals treated with the compound excrete active compounds or metabolites in urine, feces, or 
other? 
           Yes             No (If no, please justify.) 
 
 





Investigator:                                                                                                      Date:                                   
Chemical Safety Committee approval:                                                             Date:                                   

















































APPENDIX E:   
 







EXPERIMENT ONE RESULTS 
As mentioned earlier, the results of experiment one were flawed due to 
uncontrollable environmental conditions and inefficient supervision of laboratory 
systems; therefore, the results of experiment one were not discussed in earlier chapters.  
In this section, the results presented below will represent only that of experiment one.   
According to written records by the researcher, days 5-8 of the experiment took 
place during the most critical time of the category 4 hurricane, Hurricane Lili, in October 
2002.  In the course of Hurricane Lili, the university was closed and the public was 
strongly advised to remain within their homes; however, the animals were continued to 
be fed and weighed and activity was recorded throughout this time.  In spite of the effort 
to maintain experiment protocol, the expected results of the activity-based anorexia 
(ABA) model did not occur.  The ABA animals did not progressively lose weight (Figure 
13), eat less (Figure 14), or run more (Figure 15) as the experiment continued; therefore, 
the experiment terminated when the animals of the ABA group gained and maintained 
body weight. 
Nevertheless, it is not believed that the experiment protocol failed to produce the 
ABA results.  Rather, it is alleged that the results did not take place due to the 
malfunctioning of the automated lighting system.  Because there was an outage of 
electricity during these critical days of the hurricane, the lights in the laboratory did not 
turn off automatically.  Therefore, it is believed that because rats are nocturnal animals, 
the continuous light cycle interfered with the ABA model.  The animals did not 




































Figure 13.  Body Weight (Experiment One) 
Note:  NR=non-running, R=running, AL=ad libitum, RF=restricted-feeding; day 0 
























Figure 14.  Food Intake (Restricted-Feeding) 
Note:  NR=non-running, R=running, RF=restricted-feeding; day 1 represents the first 



























intake.  Because these two essential characteristics of ABA were not demonstrated, the 
ABA animals survived the ABA model. 
The results of this study indicated that the light and dark cycle is very crucial to 
the ABA model.  In addition, it further supports the requirement for elevated activity, and 
accordingly food intake suppression, to develop activity-anorexia.  Without the 12 hour 
light and dark cycles, the ABA animals will run at a rate comparable to animals exposed 
to running wheels and fed an ad libitum diet and eat at the amount comparable, if not 
more, to sedentary restricted-fed animals. 
Figure 15.  Wheel Running (Experiment One) 
Note:  R=running, RF=restricted-feeding; day 0-1 represents the first 22hr running 
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